Gösta Gahrton

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: HAEMATOLOGICA. 2025;110(1):68-77
Hematopoietic cell transplantation for older acute myeloid leukemia patients in first complete remission: results of a randomized phase III study.
Niederwieser D; Hasenclever D; Berdel WE; Biemond BJ; Al-Ali H; Chalandon Y; Van Gelder M; Junghanß C; Gahrton G; Hänel M; Hehlmann R; Heinicke T; Hochhaus A; Iacobelli S; Kooy RVM; Kröger N; Janssen J; Jentzsch M; Breywisch F; Mohty M; Masouridi-Levrat S; Ossenkoppele G; Passweg J; Pönisch W; Schetelig J; Schliemann C; Schwind S; Stelljes M; Verdonck LF; Vucinic V; Löwenberg B; Cornelissen J
Article: CANCER MEDICINE. 2023;12(22):20736-20744
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma
Nahi H; Afram G; Uttervall K; Lockmer S; Tatting L; Gahrton G; Kashif M; Alici E; Stromberg O; Klimkowska M; Lund J
Journal article: HAEMATOLOGICA. 2023
CAR-T cell treatment of high-risk multiple myeloma – will there be a cure?
Gahrton G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2022;28(5):258.e1-258.e8
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment
Reinoso-Segura M; Caballero-Velazquez T; Herrera P; Patriarca F; Fanin R; Bruno B; Einsele H; Nahi H; Granell M; Lopez-Corral L; Reguera JL; Garcia-Cadenas I; Gahrton G; Perez-Simon JA
Article: CELL REPORTS MEDICINE. 2022;3(2):100508
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Nahi H; Chrobok M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Blomberg P; Holmqvist P-H; Walther-Jallow L; Mellstrom K; Liwing J; Gustafsson C; Mansson R; Klimkowska M; Gahrton G; Lund J; Ljungman P; Ljunggren H-G; Alici E
Article: BLOOD CANCER JOURNAL. 2021;11(12):192
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Fernandez de Larrea C; Kyle R; Rosinol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; San Miguel J; Blade J; Rajkumar SV; Victoria Mateos M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):546-554
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
Afram G; Susek KH; Uttervall K; Wersall JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2020;55(9):1810-1816
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation
Costa LJ; Iacobelli S; Pasquini MC; Modi R; Giaccone L; Blade J; Schonland S; Evangelista A; Perez-Simon JA; Hari P; Brown EE; Giralt SA; Patriarca F; Stadtmauer EA; Rosinol L; Krishnan AY; Gahrton G; Bruno B
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(6):588-596
Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?
Gran C; Uttervall K; Bruchfeld JB; Wallblom A; Alici E; Gahrton G; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2019;103(3):247-254
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
Uttervall K; Bruchfeld JB; Gran C; Walinder G; Mansson R; Lund J; Gahrton G; Alici E; Nahi H
Article: PLOS ONE. 2019;14(2):e0211927
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Nahi H; Chrobok M; Gran C; Lund J; Gruber A; Gahrton G; Ljungman P; Wagner AK; Alici E
Journal article: BLOOD. 2018;132(Supplement 1):3464
Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Wolschke C; Einsele H; Itälä-Remes M; Blaise D; Niederwieser D; Meijer E; Petersen EJ; de Wreede LC; Ljungman P; Bourhis J-H; Veelken H; Beelen DW; Stelljes M; Gerbitz A; Ceballos P; Finke J; Passweg JR; Milpied N-J; Bornhäuser M; Yakoub-Agha I; Schönland S; Garderet L; Kroeger N
Article: CANCER MEDICINE. 2018;7(6):2256-2268
Lenalidomide versus lenalidomide plus dexamethasone prolonged treatment after second-line lenalidomide plus dexamethasone induction in multiple myeloma
Lund J; Gruber A; Lauri B; Duru AD; Blimark C; Swedin A; Hansson M; Forsberg K; Ahlberg L; Carlsson C; Waage A; Gimsing P; Vangsted AJ; Frolund U; Holmberg E; Gahrton G; Alici E; Hardling M; Mellqvist U-H; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(4):386-388
Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients
Gran C; Gahrton G; Alici E; Nahi H
Article: LEUKEMIA & LYMPHOMA. 2017;58(4):797-808
Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting
Garderet L; Cook G; Auner HW; Bruno B; Lokhorst H; Antonio Perez-Simon J; Sahebi F; Scheid C; Morris C; van Biezen A; Sobh M; Michallet M; Gahrton G; Schoenland S; Kroeger N
Article: LEUKEMIA. 2016;30(10):2047-2054
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party
Sobh M; Michallet M; Gahrton G; Iacobelli S; van Biezen A; Schoenland S; Petersen E; Schaap N; Bonifazi F; Volin L; Meijer E; Niederwieser D; El-Cheikh J; Tabrizi R; Fegeux N; Finke J; Bunjes D; Cornelissen J; Einsele H; Bruno B; Potter M; Fanin R; Mohty M; Garderet L; Kroeger N
Article: ANNALS OF HEMATOLOGY. 2016;95(6):967-972
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study
Gratwohl A; Iacobelli S; Bootsman N; van Biezen A; Baldomero H; Arcese W; Arnold R; Bron D; Cordonnier C; Ernst P; Ferrant A; Frassoni F; Gahrton G; Richard C; Kolb HJ; Link H; Niederwieser D; Ruutu T; Schattenberg A; Schmitz N; Torres-Gomez A; Zwaan F; Apperley J; Olavarria E; Kroeger N
Article: LEUKEMIA & LYMPHOMA. 2016;57(1):183-192
A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells
Cardona ME; Simonson OE; Oprea II; Moreno PMD; Silva-Lara MF; Mohamed AJ; Christensson B; Gahrton G; Dilber MS; Smith CIE; Arteaga HJ
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(1):46-54
Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
Nahi H; Vatsveen TK; Lund J; Heeg BMS; Preiss B; Alici E; Moller MB; Wader KF; Moller HEH; Groseth LA; Ostergaard B; Dai HY; Holmberg E; Gahrton G; Waage A; Abildgaard N
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(12):2039-2051
American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma
Giralt S; Garderet L; Durie B; Cook G; Gahrton G; Bruno B; Hari P; Lokhorst H; McCarthy P; Krishnan A; Sonneveld P; Goldschmidt H; Jagannath S; Barlogie B; Mateos M; Gimsing P; Sezer O; Mikhael J; Lu J; Dimopoulos M; Mazumder A; Palumbo A; Abonour R; Anderson K; Attal M; Blade J; Bird J; Cavo M; Comenzo R; de la Rubia J; Einsele H; Garcia-Sanz R; Hillengass J; Holstein S; Johnsen HE; Joshua D; Koehne G; Kumar S; Kyle R; Leleu X; Lonial S; Ludwig H; Nahi H; Nooka A; Orlowski R; Rajkumar V; Reiman A; Richardson P; Riva E; Miguel JS; Turreson I; Usmani S; Vesole D; Bensinger W; Qazilbash M; Efebera Y; Mohty M; Gasparreto C; Gajewski J; LeMaistre CF; Bredeson C; Moreau P; Pasquini M; Kroeger N; Stadtmauer E
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):802-807
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
Sahebi F; Iacobelli S; Biezen AV; Volin L; Dreger P; Michallet M; Ljungman PT; de Witte T; Henseler A; Schaap NPM; Lopez-Corral L; Poire X; Passweg J; Hamljadi R-M; Thomas SH; Schonland S; Gahrton G; Morris C; Kroeger N; Garderet L
Article: BONE MARROW TRANSPLANTATION. 2015;50(6):808-812
Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT
Grovdal M; Nahi H; Gahrton G; Liwing J; Waage A; Abildgaard N; Pedersen PT; Hammerstrom J; Laaksonen A; Bazia P; Terava V; Ollikainen H; Silvennoinen R; Putkonen M; Anttila P; Porkka K; Remes K
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(6):1054-1058
Efficacy and Outcome of Allogeneic Transplantation in IgD and Nonsecretory Myeloma. A Report on Behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation
Morris C; Iacobelli S; Gahrton G; van Biezen A; Drake M; Garderet L; Potter M; Schattenberg AV; Cornelissen JJ; Hamladji R-M; Martelli M; Petersen E; Rovira M; Bandini G; Kroger N; de Witte T
Journal article: ACTA HAEMATOLOGICA POLONICA. 2015;46(3):224-232
Allogeneic transplantation in multiple myeloma – How, when or at all?
Gahrton G
Article: BONE MARROW TRANSPLANTATION. 2015;50(4):505-510
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial
Iacobelli S; de Wreede LC; Schoenland S; Bjorkstrand B; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Carella AM; Beksac M; Bosi A; Milone G; Corradini P; Friberg K; van Biezen A; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Garderet L; Kroeger N; Gahrton G
Article: PLOS ONE. 2015;10(9):e0138248
Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma
Duru AD; Sutlu T; Wallblom A; Uttervall K; Lund J; Stellan B; Gahrton G; Nahi H; Alici E
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2014;164(5):684-693
Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population
Liwing J; Uttervall K; Lund J; Aldrin A; Blimark C; Carlson K; Enestig J; Flogegard M; Forsberg K; Gruber A; Kviele HH; Johansson P; Lauri B; Mellqvist U-H; Swedin A; Svensson M; Nasman P; Alici E; Gahrton G; Aschan J; Nahi H
Article: PLOS ONE. 2014;9(7):e101819
The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment
Uttervall K; Duru AD; Lund J; Liwing J; Gahrton G; Holmberg E; Aschan J; Alici E; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2014;92(1):19-25
Addition of thalidomide to melphalan and prednisone treatment prolongs survival in multiple myeloma - a retrospective population based study of 1162 patients
Lund J; Uttervall K; Liwing J; Gahrton G; Alici E; Aschan J; Holmberg E; Nahi H
Article: BONE MARROW TRANSPLANTATION. 2013;48(11):1395-1400
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation
Auner HW; Szydlo R; van Biezen A; Iacobelli S; Gahrton G; Milpied N; Volin L; Janssen J; Quoc SN; Michallet M; Schoemans H; el Cheikh J; Petersen E; Guilhot F; Schoenland S; Ahlberg L; Morris C; Garderet L; de Witte T; Kroeger N
Article: BLOOD. 2013;121(25):5055-5063
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study
Gahrton G; Iacobelli S; Bjorkstrand B; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Carella AM; Beksac M; Bosi A; Milone G; Corradini P; Schoenland S; Friberg K; van Biezen A; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Garderet L; Kroeger N
Article: LEUKEMIA. 2012;26(1):149-157
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Kumar SK; Lee JH; Lahuerta JJ; Morgan G; Richardson PG; Crowley J; Haessler J; Feather J; Hoering A; Moreau P; LeLeu X; Hulin C; Klein SK; Sonneveld P; Siegel D; Blade J; Goldschmidt H; Jagannath S; Miguel JS; Orlowski R; Palumbo A; Sezer O; Rajkumar SV; Durie BGM
Journal article: BLOOD. 2011;118(21):3340
Risk Factors of Thromboembolic Events in Multiple Myeloma Treated with IMiDs-Based Therapy While on LMWH Prophylaxis,
Leleu X; Iacobelli S; Barrois A; Pelle B; Clark L; Boyle E; Moreau P; Dib M; Caillot D; Niederwieser D; Masszi T; Fontan J; Doyen C; Hajek R; Onida F; Ludwig H; de Witte TM; Gahrton G; Morris CT; Garderet L
Article: LAKARTIDNINGEN. 2011;108(45):2261
[Palliative care. Allow active euthanasia when there is no hope of cure].
Gahrton G
Article: BLOOD. 2011;118(12):3205-3211
Approach to the treatment of multiple myeloma: a clash of philosophies
Rajkumar SV; Gahrton G; Bergsagel PL
Article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(22):3016-3022
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up
Bjorkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Gahrton G
Article: BLOOD. 2011;117(23):6063-6073
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Cavo M; Rajkumar SV; Palumbo A; Moreau P; Orlowski R; Bladé J; Sezer O; Ludwig H; Dimopoulos MA; Attal M; Sonneveld P; Boccadoro M; Anderson KC; Richardson PG; Bensinger W; Johnsen HE; Kroeger N; Gahrton G; Bergsagel PL; Vesole DH; Einsele H; Jagannath S; Niesvizky R; Durie BGM; San Miguel J; Lonial S; International Myeloma Working Group
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(16):E484
Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloma: It's Time for the Appropriate Studies Reply
Lokhorst H; Einsele H; Vesole D; Bruno B; San Miguel J; Perez-Simon JA; Kroeger NM; Moreau P; Gahrton GCA; Gasparetto C; Giralt S; Bensinger WI
Article: BLOOD. 2011;117(18):4691-4695
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Rajkumar SV; Harousseau J-L; Durie B; Anderson KC; Dimopoulos M; Kyle R; Blade J; Richardson P; Orlowski R; Siegel D; Jagannath S; Facon T; Avet-Loiseau H; Lonial S; Palumbo A; Zonder J; Ludwig H; Vesole D; Sezer O; Munshi NC; San Miguel J; International Myeloma Workshop Consensus Panel 1
Article: RECENT RESULTS IN CANCER RESEARCH. 2011;183:273-284
Allogeneic transplantation in multiple myeloma.
Gahrton G
Article: HAEMATOLOGICA. 2010;95(12):2126-2133
Efficacy and outcome of autologous transplantation in rare myelomas
Morris C; Drake M; Apperley J; Iacobelli S; van Biezen A; Bjorkstrand B; Goldschmidt H; Harousseau J-L; Morgan G; de Witte T; Niederwieser D; Gahrton G
Article: CYTOTHERAPY. 2010;12(8):1044-1055
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
Sutlu T; Stellan B; Gilljam M; Quezada HC; Nahi H; Gahrton G; Alici E
Article: LEUKEMIA RESEARCH. 2010;34(12):1627-1629
Constitutional inv(3) in myelodysplastic syndromes
Gahrton C; Nahi H; Jansson M; Wallblom A; Alici E; Sutlu T; Samuelsson J; Gahrton G
Journal article: BLOOD. 2010;116(21):3512
A Comparison of Two Different Reduced Intensity Conditioning (RIC) Allograft Strategies In Patients with Multiple Myeloma, An EBMT Analysis
Sahebi F; Garderet L; Iacobelli S; van Biezen A; Gahrton G; Kröger N; de Witte T; Morris C
Journal article: BLOOD. 2010;116(21):3043
Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation
Garderet L; Iacobelli S; Moreau P; Dib M; Caillot D; Niederwieser DW; Masszi T; Fontan J; Michallet M; Gratwohl A; Milone G; Doyen C; Pegourie B; Hajek R; Casassus P; Kolb B; Chaleteix C; Hertenstein B; Onida F; Ludwig H; Vekemans MC; Ketterer N; Daguenel A; Gorin NC; Harousseau JL; de Witte T; Morris C; Gahrton G
Article: HUMAN GENE THERAPY. 2010;21(8):929-941
TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene Therapy
Preuss E; Treschow A; Newrzela S; Bruecher D; Weber K; Felldin U; Alici E; Gahrton G; von Laer D; Dilber MS; Fehse B
Article: HAEMATOLOGICA. 2010;95(5):804-809
Primary plasma cell leukemia and autologous stem cell transplantation
Drake MB; Iacobelli S; van Biezen A; Morris C; Apperley JF; Niederwieser D; Bjorkstrand B; Gahrton G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2010;148(2):323-331
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation
Kroeger N; Shimoni A; Schilling G; Schwerdtfeger R; Bornhaueser M; Nagler A; Zander AR; Heinzelmann M; Brand R; Gahrton G; Morris C; Niederwieser D; de Witte T
Journal article: BLOOD. 2009;114(22):2308
Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Kröger N; Shimoni A; Schilling G; Schwerdtfeger R; Bornhäuser M; Nagler A; Zander AR; Heinzelmann M; Brand R; Gahrton G; Morris C; Niederwieser D; de Witte TM
Article: LEUKEMIA. 2009;23(10):1904-1912
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).
Giralt S; Stadtmauer EA; Harousseau JL; Palumbo A; Bensinger W; Comenzo RL; Kumar S; Munshi NC; Dispenzieri A; Kyle R; Merlini G; San Miguel J; Ludwig H; Hajek R; Jagannath S; Blade J; Lonial S; Dimopoulos MA; Einsele H; Barlogie B; Anderson KC; Gertz M; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Richardson PG; Niesvizky R; Rajkumar SV; Durie BGM; IMWG
Article: ONCOLOGY REPORTS. 2009;22(1):137-142
Impact of chromosome 13 deletion and plasma cell load on long-term survival of patients with multiple myeloma undergoing autologous transplantation
Paul E; Sutlu T; Deneberg S; Alici E; Bjorkstrand B; Jansson M; Lerner R; Wallblom A; Gahrton G; Nahi H
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2009;9:s9-s10
A063 Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation in Myeloma: A Prospective Trial
Gahrton G; Björkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D; Subcommitee FTECMM
Journal article: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2009;9:s27-s28
A163 Efficacy and Outcome of Autologous Transplantation in Rare Myelomas
Morris T; Drake M; Apperley J; Iaccobelli S; Niederwieser D; van Biezen A; Bjorkstrand B; Gahrton G
Journal article: BLOOD. 2008;112(11):5153
The Prognostic Significance of 8p21 Deletion in Multiple Myeloma
Nahi H; Sutlu T; Alici E; Gahrton G
Journal article: BLOOD. 2008;112(11):5148
Impact of Chromosome 13 Deletion and Plasma Cell Load on Long-Term Survival of Patients with Multiple Myeloma Undergoing Autologous Transplantation
Paul E; Sutlu T; Alici E; Gahrton G; Nahi H
Article: BLOOD. 2008;111(6):3155-3162
Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
Alici E; Sutlu T; Boejrkstrand B; Gilljam M; Stellan B; Nahi H; Quezada HC; Gahrton G; Ljunggren H-G; Dilber MS
Article: EXPERIMENTAL HEMATOLOGY. 2007;35(12):1839-1846
Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model
Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren H-G; Dilber MS
Article: HAEMATOLOGICA. 2007;92(11):1513-1518
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma
Gahrton G; Iacobelli S; Bandini G; Bjorkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kroeger N; Schattenberg A; Schoenland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D
Article: SEMINARS IN HEMATOLOGY. 2007;44(4):227-233
High-dose treatment with autologous stem cell transplantation in multiple myeloma:: Past, present, and future
Björkstrand B; Gahrton G
Article: HAEMATOLOGICA. 2007;92(8):1083-1090
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+cell selection: long term follow-up of an EBMT phase III randomized study
Bourhis J-H; Bouko Y; Koscielny S; Bakkus M; Greinix H; Derigs G; Salles G; Feremans W; Apperley J; Samson D; Bjoerkstrand B; Niederwieser D; Gahrton G; Pico J-L; Goldschmidt H
Article: BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 2007;20(2):219-229
Risk assessment in haematopoietic stem cell transplantation: Impact of donor-recipient sex combination in allogeneic transplantation
Gahrton G
Article: BLOOD. 2007;109(8):3588-3594
Reduced-intensity conditioning for myeloma:: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning
Crawley C; Iacobelli S; Bjorkstrand B; Apperley JF; Niederwieser D; Gahrton G
Article: CANCER GENE THERAPY. 2007;14(3):227-232
Long-term follow-up of gene-marked CD34⁺ cells after autologous stem cell transplantation for multiple myeloma
Alici E; Bjorkstrand B; Treschow A; Aints A; Smith CIE; Gahrton G; Dilber MS
Article: LEUKEMIA. 2006;20(9):1467-1473
International uniform response criteria for multiple myeloma
Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Article: LEUKEMIA & LYMPHOMA. 2006;47(9):1768-1773
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy plus G-CSF in patients with chronic myelogenous leukemia in first chronic phase
Olsson-Stromberg U; Hoglund M; Bjorkholm M; Braide I; Carlson K; Gahrton G; Grimfors G; Hast R; Lerner R; Linder O; Ljungman P; Lofvenberg E; Malm C; Nilsson P-G; Paul C; Rodjer S; Stenke L; Tidefeldt U; Turesson I; Uden A-M; Wahlin A; Vilen L; Winqvist I; Zettervall O; Oberg G; Simonsson B
Article: CLINICAL ADVANCES IN HEMATOLOGY AND ONCOLOGY. 2006;4(5):388-391
Pro: allogeneic transplantation in multiple myeloma.
Gahrton G
Article: BLOOD. 2006;107(6):2578-2584
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis:: a report from the European Group for Blood and Marrow Transplantation
Schönland SP; Lokhorst H; Buzyn A; Leblond V; Hegenbart U; Bandini G; Campbell A; Carreras E; Ferrant A; Grommisch L; Jacobs P; Kröger N; La Nasa G; Russell N; Zachee P; Goldschmidt H; Lacobelli S; Niederwieser D; Gahrton G
Article: CURRENT OPINION IN HEMATOLOGY. 2005;12(6):463-470
Progress in hematopoietic stem cell transplantation in multiple myeloma.
Gahrton G
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2005;62(5):429-436
Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines
Arteaga HJ; Mohamed AJ; Christensson B; Mahdy E; Gahrton G; Smith CIE; Dilber MS
Article: EXPERIMENTAL HEMATOLOGY. 2005;33(8):883-893
Identification of progression markers in B-CLL by gene expression profiling
Fält S; Merup M; Gahrton G; Lambert B; Wennborg A
Article: BLOOD. 2005;106(2):681-689
Distinctive gene expression pattern in V_H3-21 utilizing B-cell chronic lymphocytic leukemia
Fält S; Merup M; Tobin G; Thunberg U; Gahrton G; Rosenquist R; Wennborg A
Article: BLOOD. 2005;105(11):4532-4539
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma:: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
Crawley C; Lalancette M; Szydlo R; Gilleece M; Peggs K; Mackinnon S; Juliusson G; Ahlberg L; Nagler A; Shimoni A; Sureda A; Boiron JM; Einsele H; Chopra R; Carella A; Cavenagh J; Gratwohl A; Garban F; Zander A; Björkstrand B; Niederwieser D; Gahrton G; Apperley JF
Article: BONE MARROW TRANSPLANTATION. 2005;35(6):609-617
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma:: reduced relapse risk in female to male transplants
Gahrton G; Iacobelli S; Apperley J; Bandini G; Björkstrand B; Bladé J; Boiron JM; Cavo M; Cornelissen J; Corradini P; Kröger N; Ljungman P; Michallet M; Russell NH; Samson D; Schattenberg A; Sirohi B; Verdonck LF; Volin L; Zander A; Niederwieser D
Article: BONE MARROW TRANSPLANTATION. 2005;35(1):37-43
Stem cell transplantation from identical twins in patients with myelodysplastic syndromes.
Kröger N; Brand R; van Biezen A; Bron D; Blaise D; Hellström-Lindberg E; Gahrton G; Powles R; Littlewood T; Chapuis B; Zander A; Koza V; Niederwieser D; de Witte T; Myelodysplastic Syndromes Subcommittee of the Chro
Article: ACTA HAEMATOLOGICA. 2005;113(3):155-162
Intensive treatment and stem cell transplantation in chronic myelogenous leukemia:: Long-term follow-up
Simonsson B; Öberg G; Björeman M; Björkholm M; Carneskog J; Karlsson K; Gahrton G; Grimfors G; Hast R; Karle H; Linder O; Ljungman P; Nielsen JL; Nilsson J; Löfvenberg E; Malm C; Olsson K; Olsson-Strömberg U; Paul C; Stenke L; Stentoft J; Turesson I; Udén AM; Wahlin A; Vilén L; Weis-Bjerrum O
Article: HUMAN MOLECULAR GENETICS. 2004;13(23):2925-2936
Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemia
Hammarsund M; Lerner M; Zhu CY; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grandér D; Sangfelt O; Corcoran M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(9):1674-1681
Benefit and timing of second transplantations in multiple myeloma: Clinical findings and methodological limitations in a European group for blood and marrow transplantation registry study
Morris C; Iacobelli S; Brand R; Bjorkstrand B; Drake M; Niederwieser D; Gahrton G
Article: HEMATOLOGY JOURNAL. 2004;5(6):462-466
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia:: BMT prolongs survival
Olsson-Strömberg U; Simonsson B; Ahlgren T; Björkholm M; Carlsson K; Gahrton G; Hast R; Löfvenberg E; Linder O; Ljungman P; Malm C; Paul C; Rödjer S; Turesson I; Udén AM; Wahlin A; Killander A; Wadman B; Westin J; Vikrot O; Zettervall O; Öberg G
Article: BLOOD. 2003;102(5):1927-1929
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.
Corradini P; Cavo M; Lokhorst H; Martinelli G; Terragna C; Majolino I; Valagussa P; Boccadoro M; Samson D; Bacigalupo A; Russell N; Montefusco V; Voena C; Gahrton G; Chronic Leukemia Working Party of the European Gro
Article: LEUKEMIA. 2003;17(9):1827-1833
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes:: better outcome in patients with less proliferative disease
Hast R; Hellström-Lindberg E; Ohm L; Björkholm M; Celsing F; Dahl JM; Dybedal I; Gahrton G; Lindberg G; Lerner R; Linder O; Löfvenberg E; Nilsson-Ehle H; Paul C; Samuelsson J; Tangen JM; Tidefelt U; Turesson I; Wahlin A; Wallvik J; Winquist I; Öberg G; Bernell P
Article: BONE MARROW TRANSPLANTATION. 2003;32(2):121-124
The World Marrow Donor Association (WMDA): its goals and activities
Gahrton G; van Rood JJ; Oudshoorn M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;121(5):749-757
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders:: a report of the International Myeloma Working Group
Kyle RA; Child JA; Anderson K; Barlogie B; Bataille R; Bensinger W; Bladé J; Boccadoro M; Dalton W; Dimopoulos M; Djulbegovic B; Drayson M; Durie B; Facon T; Fonseca R; Gahrton G; Greipp P; Harousseau JL; Harrington D; Hussein M; Joshua D; Ludwig H; Morgan G; Oken M; Powles R; Richardson P; Roodman D; San Miguel J; Shimizu K; Shustik C; Sirohi B; Sonneveld P; Tricot G; Turesson I; Van Ness B; Vesole D; Weber D; Westin J; Wheatley K
Article: HUMAN GENE THERAPY. 2002;13(17):2085-2110
Opinion paper on the current status of the regulation of gene therapy in Europe
Cohen-Haguenauer O; Rosenthal F; Gänsbacher B; Bolhuis R; Dorsch-Häsler KD; Eshhar Z; Gahrton G; Hokland P; Melani C; Rankin E; Thielemans K; Vile R; Zwierzina H; Cichutek K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2002;68(6):376-381
Long-term follow-up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy
Öberg G; Killander A; Björeman M; Gahrton G; Grimfors G; Gruber A; Hast R; Lerner R; Liliemark J; Mattson S; Paul C; Simonsson B; Stalfelt AM; Stenke L; Tidefelt U; Udén AM; Björkholm M
Article: GENE THERAPY. 2001;8(14):1051-1056
Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting
Aints A; Güven H; Gahrton G; Smith CIE; Dilber MS
Article: CYTOKINE. 2001;14(3):136-142
Expression and release of stable and active forms of murine granulocyte-macrphage colony-stimulating factor (mGM-CSF) targeted to different subcellular compartments
Arteaga HJ; Mohamed AJ; Christensson B; Gahrton G; Smith CIE; Dilber MS
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2001;67(1):20-26
Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells
Volpe CP; Lundgren A; Aints A; Mohamed AJ; Jaakkola P; Christensson B; Gahrton G; Jalkanen M; Smith CIE; Dilber MS
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;113(1):209-216
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.
Gahrton G; Svensson H; Cavo M; Apperly J; Bacigalupo A; Björkstrand B; Bladé J; Cornelissen J; de Laurenzi A; Facon T; Ljungman P; Michallet M; Niederwieser D; Powles R; Reiffers J; Russell NH; Samson D; Schaefer UW; Schattenberg A; Tura S; Verdonck LF; Vernant JP; Willemze R; Volin L; European Group for Blood and Marrow Transplantatio
Article: BONE MARROW TRANSPLANTATION. 2001;27(5):511-515
Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma:: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT)
Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Mandelli F; Marcus R; Boogaerts M; Alegre A; Remes K; Cornelissen JJ; Bladé J; Lenhoff S; Iriondo A; Carlson K; Volin L; Littlewood T; Goldstone AH; San Miguel J; Schattenberg A; Gahrton G
Article: GENOMICS. 2000;70(3):327-334
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14
Kapanadze B; Makeeva N; Corcoran M; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontsova O; Merup M; Gahrton G; Jansson M; Yankovsky N; Einhorn S; Oscier D; Grandér D; Sangfelt O
Article: LEUKEMIA. 2000;14(1):112-118
Mutagen exposures and chromosome 3 aberrations in acute myelocytic leukemia
Lindquist R; Forsblom AM; Öst A; Gahrton G
Article: BONE MARROW TRANSPLANTATION. 1999;24(7):741-745
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
Gahrton G; Svensson H; Björkstrand B; Apperley J; Carlson K; Cavo M; Ferrant A; Fouillard L; Gratecos N; Gratwohl A; Guilhot F; Lambertenghi Deliliers G; Ljungman P; Masszi T; Milligan DW; Powles RL; Reiffers J; Samson JD; Stoppa AM; Vernant JP; Volin L; Wallvik J
Article: GENOMICS. 1999;60(2):161-171
Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates
Wu XS; Ivanova G; Merup M; Jansson M; Stellan B; Grandér D; Zabarovsky E; Gahrton G; Einhorn S
Article: PATHOLOGIE ET BIOLOGIE. 1999;47(2):188-191
Allogeneic bone marrow transplantation in multiple myeloma
Gahrton G
Article: AMERICAN JOURNAL OF PATHOLOGY. 1998;153(6):1923-1935
Lipoprotein receptors in acute myelogenous leukemia -: Failure to defect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation
Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
Article: LANCET. 1998;352(9134):1087-1092
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Gratwohl A; Hermans J; Goldman JM; Arcese W; Carreras E; Devergie A; Frassoni F; Gahrton G; Kolb HJ; Niederwieser D; Ruutu T; Vernant JP; de Witte T; Apperley J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1998;102(5):1115-1123
Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.
Bladé J; Samson D; Reece D; Apperley J; Björkstrand B; Gahrton G; Gertz M; Giralt S; Jagannath S; Vesole D
Article: LEUKEMIA. 1998;12(5):705-709
A FISH cosmid 'cocktail' for detection of 13q deletions in chronic lymphocytic leukaemia - comparison with cytogenetics and Southern hybridization
Merup M; Jansson M; Corcoran M; Liu Y; Wu X; Rasool OZ; Stellan B; Hermansson M; Juliusson G; Gahrton G; Einhorn S
Article: BLOOD. 1998;91(9):3397-3400
6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas
Merup M; Moreno TC; Heyman M; Rönnberg K; Grandér D; Detlofsson R; Rasool O; Liu Y; Söderhäll S; Juliusson G; Gahrton G; Einhorn S
Journal article: BLOOD. 1998;91(9):3397-3400
6q Deletions in Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphomas
Merup M; Moreno TC; Heyman M; Rönnberg K; Grandér D; Detlofsson R; Rasool O; Liu Y; Söderhäll S; Juliusson G; Gahrton G; Einhorn S
Article: ANTICANCER RESEARCH. 1998;18(2A):759-767
Production of a motility factor by a newly established lung adenocarcinoma cell line
Klominek J; Robért KH; Bergh J; Hjerpe A; Gahrton G; Sundqvist KG
Article: BLOOD. 1998;91(4):1382-1390
Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia
Corcoran MM; Rasool O; Liu Y; Iyengar A; Grander D; Ibbotson RE; Merup M; Wu XS; Brodyansky V; Gardiner AC; Juliusson G; Chapman RM; Ivanova G; Tiller M; Gahrton G; Yankovsky N; Zabarovsky E; Oscier DG; Einhorn S
Article: LEUKEMIA. 1997;11(12):2105-2110
Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patients.
Haglund U; Stellan B; Juliusson G; Gahrton G
Article: GENES CHROMOSOMES & CANCER. 1997;20(4):337-346
Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint
Wu XS; Merup M; Juliusson G; Jansson M; Stellan B; Grander D; Zabarovsky E; Liu Y; Spasokoukotskaja T; Gahrton G; Einhorn S
Article: ONCOGENE. 1997;15(20):2463-2473
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia
Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grander D; Iyengar A; Baranova A; Kashuba V; Merup M; Wu XS; Gardiner A; Mullenbach R; Poltaraus A; Hultstrom AL; Juliusson G; Chapman R; Tiller M; Cotter F; Gahrton G; Yankovsky N; Zabarovsky E; Einhorn S; Oscier D
Article: BONE MARROW TRANSPLANTATION. 1997;20(7):553-560
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
Article: CANCER RESEARCH. 1997;57(8):1523-1528
Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo
Dilber MS; Abedi MR; Christensson B; Bjorkstrand B; Kidder GM; Naus CCG; Gahrton G; Smith CIE
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1997;58(3):174-180
Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia
Merup M; Juliusson G; Xu XH; Jansson M; Stellan B; Rasool O; Roijer E; Stenman G; Gahrton G; Einhorn S
Article: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 1997;11(1):147-157
Allogeneic stem cell transplantation for multiple myeloma
Bensinger WI; Buckner CD; Gahrton G
Article: BLOOD. 1996;88(12):4711-4718
Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European group for blood and marrow transplantation
Bjorkstrand B; Ljungman P; Svensson H; Hermans J; Alegre A; Apperley J; Blade J; Carlson K; Cavo M; Ferrant A; Goldstone AH; deLaurenzi A; Majolino I; Marcus R; Prentice HG; Remes K; Samson D; Sureda A; Verdonck LF; Volin L; Gahrton G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;95(3):494-500
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; van Biezen A; Arcese W; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G; Iriondo A; Kolb HJ; Link H; Niederwieser D; Ruutu T; Siegert W; Zwaan FE
Article: BLOOD. 1996;88(6):2192-2200
Suicide gene therapy for plasma cell tumors
Dilber MS; Abedi MR; Bjorkstrand B; Christensson B; Gahrton G; Xanthopoulos KG; Smith CIE
Article: EUROPEAN JOURNAL OF CANCER. 1996;32A(8):1300-1302
Cancer research in the European community - Report from a meeting in Stockholm in 1995
Gahrton G; Graessmann A; Meunier F; Schmitt M; VanDongen JJM; Baig SS
Article: BONE MARROW TRANSPLANTATION. 1996;17(5):759-762
Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMT.
Samson D; Volin L; Schanz U; Bosi A; Gahrtron G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(3):647-652
Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia
Merup M; Spasokoukotskaja T; Einhorn S; Smith CIE; Gahrton G; Juliusson G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(2):251-254
Allogeneic bone marrow transplantation in multiple myeloma.
Gahrton G
Article: ANNALS OF INTERNAL MEDICINE. 1996;124(3):311-315
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia
Michallet M; Archimbaud E; Bandini G; Rowlings PA; Deeg HJ; Gahrton G; Montserrat E; Rozman C; Gratwohl A; Gale RP
Article: BRITISH JOURNAL OF HAEMATOLOGY. 1996;92(1):35-43
Indications for haemopoietic precursor cell transplants in Europe
Gratwohl A; Hermans J; Baldomero H; Tichelli A; Goldman JM; Gahrton G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(5):302-306
RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN BONE-MARROW STROMAL CELLS - STUDIES OF EFFICIENCY AND IN-VIVO SURVIVAL IN SCID MICE
LI KJ; DILBER MS; ABEDI MR; BJORKSTRAND B; SMITH CIE; GAROFF H; GAHRTON G; XANTHOPOULOS KG
Article: BLOOD. 1995;86(5):1911-1915
13Q DELETIONS IN LYMPHOID MALIGNANCIES
LIU Y; HERMANSON M; GRANDER D; MERUP M; WU XS; HEYMAN M; RASOOL O; JULIUSSON G; GAHRTON G; DETLOFSSON R; NIKIFOROVA N; BUYS C; SODERHALL S; YANKOVSKY N; ZABAROVSKY E; EINHORN S
Article: BLOOD. 1995;86(4):1614-1618
LONG-TERM EFFECTS OF HEPATITIS-C VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
LJUNGMAN P; JOHANSSON N; ASCHAN J; GLAUMANN H; LONNQVIST B; RINGDEN O; SPARRELID E; SONNERBORG A; WINIARSKI J; GAHRTON G
Article: STEM CELLS. 1995;13 Suppl 2:122-125
An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
Article: STEM CELLS. 1995;13:140-146
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA - RESULTS OF THE EUROPEAN GROUP FOR BONE-MARROW TRANSPLANTATION
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; BRANDT L; ALEGRE A; AUZANNEAU G; BLADE J; BRUNET S; CARLSON K; CAVO M; FERRANT A; GRAVETT P; DELAURENZI A; PRENTICE HG; PROCTOR S; REMES K; TROUSSARD X; VERDONCK LF; WILLIAMS C; GAHRTON G
Article: BLOOD. 1995;86(2):813-818
Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.
Gratwohl A; Hermans J; Apperley J; Arcese W; Bacigalupo A; Bandini G; di Bartolomeo P; Boogaerts M; Bosi A; Carreras E
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1995;55(1):19-23
MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON
BJORKHOLM M; LILIEMARK J; GAHRTON G; GRIMFORS G; GRUBER A; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; LJUNGMAN P; LONNQVIST B; PALMBLAD J; PAUL C; PETTERSON C; SIMONSSON B; STALFELT AM; STENKE L; SUNDSTROM C; TIDEFELT U; UDEN AM; OBERG G; OST A
Article: JOURNAL OF CLINICAL ONCOLOGY. 1995;13(6):1312-1322
Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma.
Gahrton G; Tura S; Ljungman P; Bladé J; Brandt L; Cavo M; Façon T; Gratwohl A; Hagenbeek A; Jacobs P
Article: BONE MARROW TRANSPLANTATION. 1995;15(4):619-625
SIMILAR INCIDENCE OF GRAFT-VERSUS-HOST DISEASE USING HLA-A, HLA-B AND HLA-DR IDENTICAL UNRELATED BONE-MARROW DONORS AS WITH HLA-IDENTICAL SIBLINGS
RINGDEN O; REMBERGER M; PERSSON U; LJUNGMAN P; ALDENER A; ANDSTROM E; ASCHAN J; BOLME P; DAHLLOF G; DALIANIS T; GAHRTON G; HAGGLUND H; LONNQVIST B; OLERUP O; SHANWELL A; SPARRELID E; WINIARSKI J; MOLLER E; OBERG M
Article: LAKARTIDNINGEN. 1995;92(9):849-853
[High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support].
Ljungman P; Björkstrand B; Gahrton G; Nordenström J; Shanwell A; Glas U; Rotstein S; Rutqvist LE; Wilking N
Article: BONE MARROW TRANSPLANTATION. 1995;15(3):367-371
DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION CAN INDUCE MOLECULAR REMISSIONS IN MULTIPLE-MYELOMA
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; GAHRTON G
Journal article: EXPERIMENTAL HEMATOLOGY. 1994;22(12):1129-1133
BASIC FIBROBLAST GROWTH-FACTOR INCREASES RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN HEMATOPOIETIC PERIPHERAL-BLOOD PROGENITOR CELLS
DILBER MS; BJORKSTRAND B; LI KJ; SMITH CIE; XANTHOPOULOS KG; GAHRTON G
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1994;88(2):403-405
INFECTION OF DONOR LYMPHOCYTES WITH HUMAN T-LYMPHOTROPHIC VIRUS TYPE-1 (HTLV-I) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HTLV-I POSITIVE ADULT T-CELL LEUKEMIA
LJUNGMAN P; LAWLER M; ASJO B; BOGDANOVIC G; KARLSSON K; MALM C; MCCANN SR; RINGDEN O; GAHRTON G
Journal article: HUMAN GENE THERAPY. 1994;5(10):1279-1286
RETROVIRAL-MEDIATED GENE-TRANSFER OF CD34-ENRICHED BONE-MARROW AND PERIPHERAL-BLOOD CELLS DURING AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MULTIPLE-MYELOMA
BJORKSTRAND B; GAHRTON G; DILBER MS; LJUNGMAN P; SMITH CIE; XANTHOPOULOS KG
Journal article: LEUKEMIA & LYMPHOMA. 1994;15(3-4):265-272
Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow Transplantation.
Björkstrand B; Goldstone AH; Ljungman P; Brandt L; Brunet S; Carlson K; Prentice G; Cavo M; Samson D; de Laurenzi A
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1994;88(2):325-331
RETROVIRAL-MEDIATED GENE-TRANSFER INTO HUMAN MYELOMA CELLS
BJORKSTRAND B; DILBER MS; SMITH CIE; GAHRTON G; XANTHOPOULOS KG
Journal article: BLOOD. 1994;84(2):657-663
LONG-TERM IMMUNITY TO MEASLES, MUMPS, AND RUBELLA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
LJUNGMAN P; LEWENSOHNFUCHS I; HAMMARSTROM V; ASCHAN J; BRANDT L; BOLME P; LONNQVIST B; JOHANSSON N; RINGDEN O; GAHRTON G
Journal article: LAKARTIDNINGEN. 1994;91(26-27):2577-2582
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one].
Ringdén O; Remberger M; Persson U; Ljungman P; Aschan J; Bolme P; Dahllöf G; Dalianis T; Gahrton G; Lönnqvist B
Journal article: LEUKEMIA. 1994;8(6):924-928
Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Gahrton G; Mandelli F; Carella M; Herve P; Gratwohl A; Goldman J
Journal article: BLOOD. 1994;83(9):2637-2645
HAIRY-CELL LEUKEMIA IS CHARACTERIZED BY CLONAL CHROMOSOME-ABNORMALITIES CLUSTERED TO SPECIFIC REGIONS
HAGLUND U; JULIUSSON G; STELLAN B; GAHRTON G
Journal article: BLOOD. 1994;83(9):2637-2645
Hairy Cell Leukemia Is Characterized by Clonal Chromosome Abnormalities Clustered to Specific Regions
Haglund U; Juliusson G; Stellan B; Gahrton G
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1994;86(2):291-297
T-CELL RECEPTOR-BETA GENE REARRANGEMENTS IN LEUKEMIC B-CELLS FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - ASSOCIATION WITH CHROMOSOME-6 DELETIONS
MERUP M; JULIUSSON G; HAMMARSTROM L; SMITH CIE; GAHRTON G
Journal article: LEUKEMIA & LYMPHOMA. 1994;12(5-6):343-351
Low-dose ara-C in myelodysplastic syndromes (MDS) and acute leukemia following MDS: proposal for a predictive model.
Hellström-Lindberg E; Robèrt KH; Gahrton G; Lindberg G; Forsblom AM; Kock Y; Ost A
Journal article: ANNALS OF ONCOLOGY. 1994;5:S67-S71
CHLORAMBUCIL PREDNISONE VS CHOP IN SYMPTOMATIC LOW-GRADE NON-HODGKINS-LYMPHOMAS - A RANDOMIZED TRIAL FROM THE LYMPHOMA-GROUP-OF-CENTRAL-SWEDEN
KIMBY E; BJORKHOLM M; GAHRTON G; GLIMELIUS B; HAGBERG H; JOHANSSON B; JOHANSSON H; JULIUSSON G; JARNMARK M; LOFVENBERG E; KILLANDER A; LERNER R; LINDEMALM C; PETTERSSON U; ROBERT KH; SIMONSSON B; STALFELT AM; SUNDSTROM C; SVEDMYR E; UDEN AM; WADMAN B; WAHLIN A; OST A; MELLSTEDT H
Journal article: BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY. 1993;6(4):821-848
CYTOGENETICS IN CLL AND RELATED DISORDERS
JULIUSSON G; GAHRTON G
Journal article: BONE MARROW TRANSPLANTATION. 1993;12(5):509-516
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
Journal article: BLOOD. 1993;82(6):1938-1939
CHROMOSOME-ABNORMALITIES AND RB1 GENE DELETIONS IN CHRONIC LYMPHOCYTIC-LEUKEMIA
JULIUSSON G; GAHRTON G; EINHORN S; LIU Y; OSCIER DG; CHAPMAN R
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1993;90(18):8697-8701
CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS WITH ALLELIC DELETIONS AT 13Q14 COMMONLY HAVE ONE INTACT RB1 GENE - EVIDENCE FOR A ROLE OF AN ADJACENT LOCUS
LIU Y; SZEKELY L; GRANDER D; SODERHALL S; JULIUSSON G; GAHRTON G; LINDER S; EINHORN S
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1993;51(1):45-49
ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (EACB) AS OUTPATIENT SALVAGE THERAPY FOR REFRACTORY MULTIPLE-MYELOMA
OHRLING M; BJORKHOLM M; OSTERBORG A; JULIUSSON G; BJOREMAN M; BRENNING G; CARLSON K; CELSING F; GAHRTON G; GRIMFORS G; GRUBER A; GYLLENHAMMAR H; HAST R; JOHANSSON B; JARNMARK M; KIMBY E; LERNER R; LINDER O; MERK K; PAUL C; SIMONSSON B; SMEDMYR B; SVEDMYR E; STALFELT AM; UDEN AM; OSBY E; MELLSTEDT H
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1993;84(1):61-66
BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOBLASTIC-LEUKEMIA - AN EBMT-LEUKEMIA-WORKING-PARTY PROSPECTIVE ANALYSIS FROM HLA-TYPING
LJUNGMAN P; DEWITTE T; VERDONCK L; GAHRTON G; FREYCON F; GRAVETT P; MCCANN S; MORGENSTERN HG; NIKOSKELAINEN J; POWLES R; PROCTOR SJ; VOLIN L; ZWAAN F; GRATWOHL A
Journal article: JOURNAL OF INTERNAL MEDICINE. 1993;233(4):333-341
BONE-MARROW TRANSPLANTATION IN EUROPE - MAJOR GEOGRAPHICAL DIFFERENCES
GRATWOHL A; HERMANS J; GOLDMAN JM; GAHRTON G
Journal article: BLOOD. 1993;81(6):1428-1434
NATURAL INTERFERON-ALPHA IN COMBINATION WITH MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA STAGE-II AND STAGE-III - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
OSTERBORG A; BJORKHOLM M; BJOREMAN M; BRENNING G; CARLSON K; CELSING F; GAHRTON G; GRIMFORS G; GYLLENHAMMAR H; HAST R; JOHANSSON B; JULIUSSON G; JARNMARK M; KIMBY E; LERNER R; LINDER O; MERK K; NILSSON B; OHRLING M; PAUL C; SIMONSSON B; SMEDMYR B; SVEDMYR E; STALFELT AM; STRANDER H; UDEN AM; OSBY E; MELLSTEDT H
Journal article: LAKARTIDNINGEN. 1993;90(10):948-950
[Bone marrow transplantation. A EEC-project with unrelated donors saves more and more people].
Gahrton G; Bolme P; Ljungman P; Persson U; Ringdén O
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1993;83(1):118-124
CYTOMEGALOVIRUS VIREMIA AND SPECIFIC T-HELPER CELL RESPONSES AS PREDICTORS OF DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
LJUNGMAN P; ASCHAN J; AZINGE JN; BRANDT L; EHRNST A; HAMMARSTROM V; KLAESSON S; LINDE A; LONNQVIST B; RINGDEN O; WAHREN B; GAHRTON G
Journal article: LEUKEMIA & LYMPHOMA. 1993;11 Suppl 1:227-231
Splenic irradiation before bone marrow transplantation for chronic myeloid leukemia: update of a prospective randomized study.
Gratwohl A; Hermans J; Biezen AV; Arcese W; de Witte T; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1992;81(4):503-511
A PREDICTIVE MODEL FOR THE CLINICAL-RESPONSE TO LOW-DOSE ARA-C - A STUDY OF 102 PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE-LEUKEMIA
HELLSTROMLINDBERG E; ROBERT KH; GAHRTON G; LINDBERG G; FORSBLOM AM; KOCK Y; OST A
Journal article: BONE MARROW TRANSPLANTATION. 1992;10(2):147-152
No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia: results of a prospective randomized study.
Gratwohl A; Hermans J; von Biezen A; Arcese W; de Witte T; Debusscher L; Ernst P; Ferrant A; Frassoni F; Gahrton G
Journal article: LEUKEMIA & LYMPHOMA. 1992;7(1-2):7-14
Bone marrow transplantation for acute non-lymphoblastic leukemia.
Ljungman P; Gahrton G
Journal article: JOURNAL OF INTERNAL MEDICINE. 1992;231(5):449-452
MULTIPLE-MYELOMA - A CURABLE DISEASE
GAHRTON G
Journal article: LAKARTIDNINGEN. 1992;89(16):1379-1380
[Randomization and ethics. Patient participation is a serious demand in medical research].
Hermerén G; Hjemdahl P; Gahrton G
Journal article: GENES CHROMOSOMES & CANCER. 1992;4(3):250-256
RETINOBLASTOMA GENE DELETIONS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
LIU Y; GRANDER D; SODERHALL S; JULIUSSON G; GAHRTON G; EINHORN S
Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 1991;325(18):1267-1273
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA
GAHRTON G; TURA S; LJUNGMAN P; BELANGER C; BRANDT L; CAVO M; FACON T; GRANENA A; GORE M; GRATWOHL A; LOWENBERG B; NIKOSKELAINEN J; REIFFERS JJ; SAMSON D; VERDONCK L; VOLIN L
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1991;79:21-25
TREATMENT OF MULTIPLE-MYELOMA WITH INTERFERON-ALPHA - THE SCANDINAVIAN EXPERIENCE
MELLSTEDT H; OSTERBORG A; BJORKHOLM M; BJOREMAN M; BRENNING G; GAHRTON G; GRIMFORS G; GYLLENHAMMAR H; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; MERK K; OHRLING M; SIMONSSON B; SMEDMYR B; STALFELT AM; STRANDER H; SVEDMYR E; UDEN AM; WADMAN D; OSBY E
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1991;47(2):98-103
ACUTE-LEUKEMIA IN PROFESSIONAL DRIVERS EXPOSED TO GASOLINE AND DIESEL
LINDQUIST R; NILSSON B; EKLUND G; GAHRTON G
Journal article: CLINICAL TRANSPLANTATION. 1991;5(4):283-286
Hepatitis C infection in allogeneic bone marrow transplant recipients
Ljungman P; Duraj V; Magnius L; Aschan J; Lönnqvist B; Ringdén O; Gahrton G
Journal article: LAKARTIDNINGEN. 1991;88(25):2308-2311
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life].
Ljungman P; Aschan J; Bolme P; Lindqvist R; Lönnqvist B; Ringdén O; Winiarski J; Gahrton G
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1991;46(5):314-316
SIMULTANEOUSLY PRESENTING APLASTIC-ANEMIA AND HODGKINS-DISEASE SUCCESSFULLY TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION
JULIUSSON G; HAST R; LJUNGMAN P; BJORKHOLM M; LONNQUIST B; SANDSTEDT B; BARYD I; RINGDEN O; GAHRTON G
Journal article: BONE MARROW TRANSPLANTATION. 1991;7(2):113-119
METHOTREXATE COMBINED WITH CYCLOSPORINE-A DECREASES GRAFT-VERSUS-HOST DISEASE, BUT INCREASES LEUKEMIC RELAPSE COMPARED TO MONOTHERAPY
ASCHAN J; RINGDEN O; SUNDBERG B; GAHRTON G; LJUNGMAN P; WINIARSKI J
Journal article: BONE MARROW TRANSPLANTATION. 1991;7(2):71-79
BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA
BARLOGIE B; GAHRTON G
Journal article: LEUKEMIA & LYMPHOMA. 1991;3(5-6):355-364
A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.
Paul C; Tidefelt U; Gahrton G; Björkholm M; Järnmark M; Killander A; Kimby E; Liliemark J; Lindeberg A; Lindquist R; Lockner D; Lönnqvist B; Mellstedt H; Merk K; Palmblad J; Peterson C; Simonsson B; Stalfelt AM; Sundström C; Wadman B; Wedelin C; Udén AM; Öberg G; Öst Å
Journal article: EUROPEAN JOURNAL OF CANCER. 1991;27:S51-S52
MELPHALAN PREDNISONE VERSUS MELPHALAN PREDNISONE PLUS HUMAN ALPHA INTERFERON THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA, STAGE-II AND STAGE-III
BJORKHOLM M; MELLSTEDT H; OSTERBORG A; BJOREMAN M; LERNER R; MERK K; BRENNING G; OHRLING M; GAHRTON G; SIMONSSON B; GRIMFORS G; SMEDMYR B; GYLLENHAMAR H; STALFELT A; HAST R; STRANDER H; JULIUSSON G; SVEDMYR E; JARNMARK M; UDEN A; KILLANDER A; WADMAN B; KIMBY E; OSBY E
Journal article: BONE MARROW TRANSPLANTATION. 1991;7 Suppl 2:32
Allogeneic bone marrow transplantation in multiple myeloma using HLA-compatible sibling donors--an EBMT Registry Study.
Gahrton G; Tura S; Ljungman P; Belanger B; Brandt L; Cavo M; Chapuis B; De Laurenzi A; de Witte T; Facon T
Journal article: EUROPEAN JOURNAL OF CANCER. 1991;27(12):1537-1539
BONE-MARROW TRANSPLANTATION WITH UNRELATED VOLUNTEER DONORS
GAHRTON G
Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 1990;323(11):720-724
PROGNOSTIC SUBGROUPS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA DEFINED BY SPECIFIC CHROMOSOMAL-ABNORMALITIES
JULIUSSON G; OSCIER DG; FITCHETT M; ROSS FM; STOCKDILL G; MACKIE MJ; PARKER AC; CASTOLDI GL; CUNEO A; KNUUTILA S; ELONEN E; GAHRTON G
Journal article: CANCER GENETICS. 1990;48(2):183-192
NO EVIDENCE OF TRISOMY-12 OR T(11,14) BY MOLECULAR GENETIC TECHNIQUES IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS WITH A NORMAL KARYOTYPE
EINHORN S; MEEKER T; JULIUSSON G; BURVALL K; GAHRTON G
Journal article: JOURNAL OF INFECTIOUS DISEASES. 1990;162(2):496-500
RESPONSE TO TETANUS TOXOID IMMUNIZATION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
LJUNGMAN P; WIKLUNDHAMMARSTEN M; DURAJ V; HAMMARSTROM L; LONNQVIST B; PAULIN T; RINGDEN O; PEPE MS; GAHRTON G
Journal article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1990;87(7):2598-2602
UPTAKE OF LOW-DENSITY LIPOPROTEINS BY HUMAN LEUKEMIC-CELLS INVIVO - RELATION TO PLASMA-LIPOPROTEIN LEVELS AND POSSIBLE RELEVANCE FOR SELECTIVE CHEMOTHERAPY
VITOLS S; ANGELIN B; ERICSSON S; GAHRTON G; JULIUSSON G; MASQUELIER M; PAUL C; PETERSON C; RUDLING M; SODERBERGREID K; TIDEFELT U
Journal article: CANCER GENETICS. 1990;45(2):143-160
CHROMOSOME-ABERRATIONS IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - PATHOGENETIC AND CLINICAL IMPLICATIONS
JULIUSSON G; GAHRTON G
Journal article: BONE MARROW TRANSPLANTATION. 1990;5(3):159-165
Allogeneic bone marrow transplantation for leukemia in Europe: regional differences. Report from the Leukemia Working party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Barrett AJ; Ernst P; Frassoni F; Gahrton G; Granena A; Kolb HJ; Prentice HG; Vernant JP
Journal article: ACTA ONCOLOGICA. 1990;29(6):727-731
ORAL VERSUS INTRAVENOUS MELPHALAN AND PREDNISONE TREATMENT IN MULTIPLE-MYELOMA STAGE-II - A RANDOMIZED STUDY FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
OSTERBORG A; AHRE A; BJORKHOLM M; BJOREMAN M; BRENNING G; GAHRTON G; GRIMFORS G; GYLLENHAMMAR H; HAST R; JOHANSSON B; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; NILSSON B; PAUL C; SIMONSSON B; STALFELT AM; SMEDMYR B; SVEDMYR E; UDEN AM; WADMAN B; OSBY E; MELLSTEDT H
Journal article: CLINICAL TRANSPLANTS. 1990;:175-187
Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
Ringdén O; Aschan J; Boström L; Dahllöf G; Tollemar J; Paulin T; Gahrton G; Groth CG; Klaesson S; Lindquist R
Journal article: LEUKEMIA. 1989;3(12):871-874
MOLECULAR ANALYSES OF CHROMOSOME-12 IN CHRONIC LYMPHOCYTIC-LEUKEMIA
EINHORN S; BURVALL K; JULIUSSON G; GAHRTON G; MEEKER T
Journal article: BONE MARROW TRANSPLANTATION. 1989;4 Suppl 4:4-6
Allogeneic bone marrow transplantation in haematological malignancies. Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
Gahrton G; Gratwohl A; Ernst P; Hermans J; Lyklema A; Zwaan FE
Journal article: BONE MARROW TRANSPLANTATION. 1989;4(6):613-615
A RANDOMIZED TRIAL OF ORAL VERSUS INTRAVENOUS ACYCLOVIR FOR TREATMENT OF HERPES-ZOSTER IN BONE-MARROW TRANSPLANT RECIPIENTS
LJUNGMAN P; LONNQVIST B; RINGDEN O; SKINHOJ P; GAHRTON G
Journal article: CANCER RESEARCH. 1989;49(21):6118-6122
SERUM-DEPENDENT GROWTH-PATTERNS OF 2, NEWLY ESTABLISHED HUMAN MESOTHELIOMA CELL-LINES
KLOMINEK J; ROBERT KH; HJERPE A; WICKSTROM B; GAHRTON G
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1989;43(1):54-62
ALTERNATING COMBINATION CHEMOTHERAPY (VMCP/VBAP) IS NOT SUPERIOR TO MELPHALAN PREDNISONE IN THE TREATMENT OF MULTIPLE-MYELOMA PATIENTS STAGE-III - A RANDOMIZED STUDY FROM MGCS
OSTERBORG A; AHRE A; BJORKHOLM M; BJOREMAN M; BRENNING G; GAHRTON G; GYLLENHAMMAR H; JOHANSSON B; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; NILSSON B; PAUL C; SIMONSSON B; STALFELT AM; STRANDER H; SMEDMYR B; SVEDMYR E; UDEN AM; WADMAN B; WEDELIN C; MELLSTEDT H
Journal article: JOURNAL OF INFECTIOUS DISEASES. 1989;159(4):610-615
EFFICACY AND SAFETY OF VACCINATION OF MARROW TRANSPLANT RECIPIENTS WITH A LIVE ATTENUATED MEASLES, MUMPS, AND RUBELLA VACCINE
LJUNGMAN P; FRIDELL E; LONNQVIST B; BOLME P; BOTTIGER M; GAHRTON G; LINDE A; RINGDEN O; WAHREN B
Journal article: CLINICAL TRANSPLANTATION. 1989;3(1):12-18
BONE-MARROW TRANSPLANTATION IN CHILDREN
RINGDEN O; BOLME P; LONNQVIST B; TOLLEMAR J; DAHLLOF G; GAHRTON G; GROTH CG
Journal article: THERAPEUTIC DRUG MONITORING. 1989;11(2):140-148
PHARMACOKINETICS OF DAUNORUBICIN AND DOXORUBICIN IN PLASMA AND LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA
PAUL C; LILIEMARK J; TIDEFELT U; GAHRTON G; PETERSON C
Journal article: ACTA ONCOLOGICA. 1989;28(1):135-140
MANAGEMENT OF NON-HODGKIN LYMPHOMA IN ADULTS IN SCANDINAVIA, UNITED-KINGDOM, AND THE NETHERLANDS - REPORT FROM THE EUROPEAN-SCHOOL-OF-ONCOLOGY INTERCITY MEETING AT HUDDINGE-HOSPITAL, 3RD JUNE, 1988
JULIUSSON G; ABRAHAMSEN AF; CAVALLINSTAHL E; GOLDSTONE AH; LISTER TA; NISSEN NI; ROBERT KH; SINGER CRJ; SOMERS R; OST A; GAHRTON G
Journal article: LEUKEMIA RESEARCH. 1989;13(12):1113-1121
EFFECTS OF RETINOIC ACID, 1,25-DIHYDROXYVITAMIN-D3, CYTOSINE-ARABINOSIDE AND ALPHA-INTERFERON ON BONE-MARROW CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES
HELLSTROM E; ROBERT KH; SOPPI E; OST A; PUTKONEN PO; GAHRTON G
Journal article: BONE MARROW TRANSPLANTATION. 1988;3(6):583-588
ANTI-DNA ANTIBODY-SYNTHESIS AFTER BONE-MARROW TRANSPLANTATION - IMPLICATIONS FOR IGG SUBCLASS RESTRICTIVITY AND PATHOGENICITY OF AUTOANTIBODIES
SMITH CIE; NORBERG R; ISENBERG D; STAINES NA; GAHRTON G; RINGDEN O; HAMMARSTROM L
Journal article: BONE MARROW TRANSPLANTATION. 1988;3(5):413-423
RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME POSITIVE CHRONIC MYELOID-LEUKEMIA - CYTOGENETIC ANALYSIS OF 24 PATIENTS
ZACCARIA A; ROSTI G; SESSAREGO M; FRASSONI F; MARMONT A; GALIMBERTI M; BARONCIANI D; FILIPPETTI A; DIBARTOLOMEO P; DIGIROLAMO G; PALKA G; TESTONI N; CELSO B; BANDINI G; RICCI P; TASSINARI A; HINTERBERGER W; POLLAK C; HAAS OA; ARNOLD R; HEINZE B; MICHAUX JL; FERRANT A; MECUCCI C; VANDENBERGHE H; GAHRTON G; LINDQUIST R; TURA S
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1988;41(2):123-130
High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS).
Ahre A; Björkholm M; Osterborg A; Brenning G; Gahrton G; Gyllenhammar H; Holm G; Johansson B; Juliusson G; Järnmark M
Journal article: CANCER. 1988;62(3):500-506
CONSISTENCY OF CHROMOSOMAL-ABERRATIONS IN CHRONIC B-LYMPHOCYTIC LEUKEMIA - A LONGITUDINAL CYTOGENETIC STUDY OF 41 PATIENTS
JULIUSSON G; FRIBERG K; GAHRTON G
Journal article: BONE MARROW TRANSPLANTATION. 1988;3(4):281-290
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - FACTORS OF IMPORTANCE FOR LONG-TERM SURVIVAL AND RELAPSE
RINGDEN O; SUNDBERG B; LONNQVIST B; TOLLEMAR J; GAHRTON G; NILSSON B
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1988;41(1):66-73
CLONAL ANALYSIS OF THE RESPONSE OF HL-60 CELLS TO RETINOIC ACID AND VITAMIN-D IN THE PRESENCE OR ABSENCE OF LEUKOCYTE-CONDITIONED MEDIUM
SOPPI E; ROBERT KH; GAHRTON G
Journal article: TRANSPLANTATION PROCEEDINGS. 1988;20(3):487-490
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHILDREN AT HUDDINGE-HOSPITAL
RINGDEN O; BOLME P; LONNQVIST B; TOLLEMAR J; BORGSTROM B; DOHLHOF G; LUNDGREN G; WINIARSKI J; GAHRTON G; GROTH CG
Journal article: TRANSPLANTATION PROCEEDINGS. 1988;20(3):494-498
DECREASED INCIDENCE OF GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION RECIPIENTS TREATED WITH A COMBINATION OF CYCLOSPORINE AND METHOTREXATE
TOLLEMAR J; RINGDEN O; SUNDBERG B; BOLME P; BRATTSTROM C; GAHRTON G; JOHANSEN L; LONNQVIST B
Journal article: LAKARTIDNINGEN. 1988;85(19):1707-1713
[Multiple myeloma--pathophysiology and treatment].
Gahrton G; Björkholm M; Mellstedt H; Ost A
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1988;40(5):449-459
THERAPEUTIC EFFECTS OF LOW-DOSE CYTOSINE-ARABINOSIDE, ALPHA-INTERFERON, 1-ALPHA-HYDROXYVITAMIN-D3 AND RETINOIC ACID IN ACUTE-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
HELLSTROM E; ROBERT KH; GAHRTON G; MELLSTEDT H; LINDEMALM C; EINHORN S; BJORKHOLM M; GRIMFORS G; UDEN AM; SAMUELSSON J; OST A; KILLANDER A; NILSSON B; WINQVIST I; OLSSON I
Journal article: HEMATOLOGICAL ONCOLOGY. 1988;6(2):181-186
Allogeneic bone marrow transplantation in 24 patients with multiple myeloma reported to the EBMT registry.
Gahrton G; Tura S; Flesch M; Gratwohl A; Gravett P; Lindeberg A; Lucarelli G; Michallet M; Reiffers J; Ringdén O
Journal article: BONE MARROW TRANSPLANTATION. 1988;3:227
REDUCTION OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH METHOTREXATE COMBINED WITH CYCLOSPORIN
TOLLEMAR J; RINGDEN O; BARKHOLT L; BOLME P; DAHLLOF G; GAHRTON G; HEIMDAHL A; LINDQUIST R; LJUNGMAN P; LONNQVIST B; MOLLER E; PAULIN T; SUNDBERG B
Journal article: BONE MARROW TRANSPLANTATION. 1988;3:184
RELAPSE AFTER ALLOGENEIC BMT FOR PH-1+ CML IN CP - A CYTOGENETIC ANALYSIS OF 13 CASES
ROSTI G; ZACCARIA A; TESTONI N; CELSO B; BANDINI G; RICCI P; TASSINARI A; TURA S; SESSAREGO M; FRASSONI F; MARMONT A; BARONCIANI D; FILIPPETTI A; DIBARTOLOMEO P; DIGIROLAMO G; PALKA G; HINTERBERGER W; POLLAK C; HAAS OA; ARNOLD R; HEINZE B; MICHAUX JL; FERRANT A; MECUCCI C; VANDENBERGHE H; GAHRTON G; LINDQUIST R
Journal article: NOUVELLE REVUE FRANCAISE D'HEMATOLOGIE. 1988;30(5-6):389-392
CLINICAL IMPLICATION OF CHROMOSOMAL-ABERRATIONS IN CHRONIC B-LYMPHOCYTIC LEUKEMIA-CELLS
GAHRTON G; JULIUSSON G
Journal article: NOUVELLE REVUE FRANCAISE D'HEMATOLOGIE. 1988;30(5-6):399-401
CLINICAL IMPLICATIONS OF CLL CELL-PROLIFERATION INVITRO
JULIUSSON G; GAHRTON G
Journal article: ONCOGENE RES. 1988;3(1):39-49
INFLUENCE OF INTERFERON-ALPHA ON THE EXPRESSION OF CELLULAR ONCOGENES IN PRIMARY CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
EINHORN S; SHOWE L; OSTLUND L; JULIUSSON G; ROBERT KH; GAHRTON G; CROCE C
Journal article: ACTA ONCOLOGICA. 1988;27(5):473-477
CHROMOSOMAL-ABERRATIONS IN PROGRESSIVE AND INDOLENT CHRONIC B-LYMPHOCYTIC LEUKEMIA - A LONGITUDINAL-STUDY
JULIUSSON G; FRIBERG K; GAHRTON G
Journal article: NORDISK MEDICIN. 1988;103(4):116-119
[Bone marrow transplantation--rapid development toward new indications].
Gahrton G; Ringdén O; Robèrt KH
Journal article: ACTA ONCOLOGICA. 1988;27(5):557-565
Allogeneic bone marrow transplantation in leukemia.
Gratwohl A; Gahrton G
Journal article: CANCER. 1987;60(6):1378-1384
INCREASED RISK OF DEVELOPING ACUTE-LEUKEMIA AFTER EMPLOYMENT AS A PAINTER
LINDQUIST R; NILSSON B; EKLUND G; GAHRTON G
Journal article: BLOOD REVIEWS. 1987;1(3):183-192
Role of chromosomal abnormalities in chronic lymphocytic leukemia.
Gahrton G; Juliusson G; Robèrt KH; Friberg K
Journal article: SEMINARS IN ONCOLOGY. 1987;14(2):167-171
ARA-C IN PLASMA AND ARA-CTP IN LEUKEMIC-CELLS AFTER SUBCUTANEOUS INJECTION AND CONTINUOUS INTRAVENOUS-INFUSION OF ARA-C IN PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA
LILIEMARK JO; GAHRTON G; PAUL CY; PETERSON CO
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1987;38(S47):5
INTRODUCTION
Gahrton G
Journal article: CANCER GENETICS. 1987;26(1):5-13
CHROMOSOME-STUDIES IN PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA SUBMITTED TO BONE-MARROW TRANSPLANTATION - RESULTS OF A EUROPEAN COOPERATIVE STUDY
ZACCARIA A; ROSTI G; TESTONI N; ALIMENA G; ARCESE W; BANDINI G; BOOGAERTS M; CARBONELL F; FERRANT A; FILIPPETTI A; FRASSONI F; GAHRTON G; HAAS OA; IACONE A; MECUCCI C; MICHAUX JL; PALKA G; PAPA G; POLLAK C; ROSETTI A; RICCI P; SCHMEIZER T; SESSAREGO M; VALENTI S; VANDENBERGHE H; TURA S
Journal article: CANCER GENETICS. 1987;26(1):51-58
CHROMOSOME-STUDIES IN PATIENTS WITH ACUTE NONLYMPHOCYTIC OR ACUTE LYMPHOCYTIC-LEUKEMIA SUBMITTED TO BONE-MARROW TRANSPLANTATION - RESULTS OF A EUROPEAN COOPERATIVE STUDY
ZACCARIA A; ROSTI G; TESTONI N; ARNOLD R; BANDINI G; BECHER R; BOOGAERTS M; CARBONELL F; DIBARTOLOMEO P; FERRANT A; FILIPPETTI A; FRASSONI F; GAHRTON G; HAAS OA; MECUCCI C; MICHAUX JL; PALKA G; POLLAK C; RICCI P; ROSETTI A; SESSAREGO M; VALENTI S; VANDENBERGHE H; TURA S
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1987;38(4):315-317
POOR AGE-CORRECTED SURVIVAL OF CHRONIC LYMPHOCYTIC-LEUKEMIA PATIENTS WITH TRISOMY-12
JULIUSSON G; GAHRTON G
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1987;38(4):350-355
Graft-versus-leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft-versus-host disease in allograft recipients with AML.
Jacobsen N; Lönnqvist B; Ringdén O; Rajantie J; Siimes MA; Volin L; Ruutu T; Nikoskelainen J; Toivanen A; Ryder L
Journal article: BLOOD. 1987;69(4):1262-1264
Bone Marrow Transplantation in Multiple Myeloma: Report From the European Cooperative Group for Bone Marrow Transplantation
Gahrton G; Tura S; Flesch M; Gratwohl A; Gravett P; Lucarelli G; Michallet M; Reiffers J; Ringdén O; van Lint MT; Vernant JP; Zwaan FE
Journal article: BLOOD. 1987;69(4):1262-1264
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation.
Gahrton G; Tura S; Flesch M; Gratwohl A; Gravett P; Lucarelli G; Michallet M; Reiffers J; Ringdén O; van Lint MT
Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 1987;316(12):733-735
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A PATIENT WITH CHEMOTHERAPY-RESISTANT PROGRESSIVE HISTIOCYTOSIS-X
RINGDEN O; AHSTROM L; LONNQVIST B; BARYD I; SVEDMYR E; GAHRTON G
Journal article: TRANSPLANTATION. 1987;43(3):393-398
VARIABLES PREDICTING BACTERIAL AND FUNGAL-INFECTIONS AFTER ALLOGENEIC MARROW ENGRAFTMENT
PAULIN T; RINGDEN O; NILSSON B; LONNQVIST B; GAHRTON G
Journal article: LANCET. 1987;1(8530):456-457
Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia.
Jacobsen N; Keiding N; Ryder L; Ringdén O; Lönnqvist B; Gahrton G; Rajantie J; Siimes M; Volin L; Ruutu T
Journal article: BONE MARROW TRANSPLANTATION. 1986;1(2):185-192
LONG-TERM ACYCLOVIR PROPHYLAXIS IN BONE-MARROW TRANSPLANT RECIPIENTS AND LYMPHOCYTE-PROLIFERATION RESPONSES TO HERPESVIRUS ANTIGENS INVITRO
LJUNGMAN P; WILCZEK H; GAHRTON G; GUSTAVSSON A; LUNDGREN G; LONNQVIST B; RINGDEN O; WAHREN B
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1986;37(5):363-370
ACTIVATION OF MALIGNANT LYMPHOCYTES-B - PATHOPHYSIOLOGIC AND CLINICAL IMPORTANCE
ROBERT KH; JULIUSSON G; EINHORN S; BIBERFELD P; GAHRTON G
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1986;63(4):671-679
Reduced risk of recurrent leukaemia in bone marrow transplant recipients after cytomegalovirus infection.
Lönnqvist B; Ringdèn O; Ljungman P; Wahren B; Gahrton G
Journal article: BLOOD. 1986;68(1):108-112
Cytomegalovirus-Specific Lymphocyte Proliferation and In Vitro Cytomegalovirus IgG Synthesis for Diagnosis of Cytomegalovirus Infections After Bone Marrow Transplantation
Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Wahren B
Journal article: BLOOD. 1986;68(1):108-112
Cytomegalovirus-specific lymphocyte proliferation and in vitro cytomegalovirus IgG synthesis for diagnosis of cytomegalovirus infections after bone marrow transplantation.
Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Wahren B
Journal article: BONE MARROW TRANSPLANTATION. 1986;1(1):41-51
A RANDOMIZED TRIAL COMPARING USE OF CYCLOSPORINE AND METHOTREXATE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH HEMATOLOGICAL MALIGNANCIES
RINGDEN O; BACKMAN L; LONNQVIST B; HEIMDAHL A; LINDHOLM A; BOLME P; GAHRTON G
Journal article: JOURNAL OF INFECTIOUS DISEASES. 1986;153(5):840-847
Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients.
Ljungman P; Lönnqvist B; Gahrton G; Ringdén O; Sundqvist VA; Wahren B
Journal article: ACTA MEDICA SCANDINAVICA. 1986;219(5):523-527
Bone marrow transplantation in three patients with multiple myeloma.
Gahrton G; Ringdén O; Lönnqvist B; Lindquist R; Ljungman P
Journal article: ACTA MEDICA SCANDINAVICA. 1986;220(3):255-260
CLINICAL FINDINGS AND PROGNOSTIC FACTORS IN CHRONIC MYELOID LEUKEMIAS
WEDELIN C; BJORKHOLM M; MELLSTEDT H; GAHRTON G; HOLM G
Journal article: ACTA MEDICA SCANDINAVICA. 1986;219(5):433-434
BONE-MARROW TRANSPLANTATION IN MULTIPLE-MYELOMA
GAHRTON G; RINGDEN O; LONNQVIST B
Journal article: TRANSPLANTATION PROCEEDINGS. 1986;18(1):119-122
THE STOCKHOLM EXPERIENCE WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION
RINGDEN O; BOLME P; BORGSTROM B; GAHRTON G; GROTH CG; LINDHOLM A; LINDQUIST R; LJUNGMAN P; LUNDGREN G; LONNQVIST B; MOLLER E; ROBERT KH; OST L
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. SUPPLEMENTUM. 1986;36:61-74
ACUTE MYELOGENOUS LEUKEMIA OF UNFAVORABLE PROGNOSIS TREATED WITH RETINOIC ACID, VITAMIN-D3, ALPHA-INTERFERON AND LOW-DOSES OF CYTOSINE-ARABINOSIDE
ROBERT KH; HELLSTROM E; EINHORN S; GAHRTON G
Journal article: CANCER GENETICS. 1985;18(4):307-313
ABNORMAL NORMAL METAPHASE RATIO AND PROGNOSIS IN CHRONIC B-LYMPHOCYTIC LEUKEMIA
JULIUSSON G; GAHRTON G
Journal article: LANCET. 1985;2(8465):1150-1154
HYPOCHOLESTEROLEMIA IN MALIGNANCY DUE TO ELEVATED LOW-DENSITY-LIPOPROTEIN-RECEPTOR ACTIVITY IN TUMOR-CELLS - EVIDENCE FROM STUDIES IN PATIENTS WITH LEUKEMIA
VITOLS S; BJORKHOLM M; GAHRTON G; PETERSON C
Journal article: TRANSPLANTATION. 1985;40(5):515-520
LYMPHOCYTE-RESPONSES AFTER CYTOMEGALO-VIRUS INFECTION IN BONE-MARROW TRANSPLANT RECIPIENTS - A ONE-YEAR FOLLOW-UP
LJUNGMAN P; LONNQVIST B; WAHREN B; RINGDEN O; GAHRTON G
Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1985;131(2):579-585
STIMULATION OF HUMAN MYELOPOIESIS BY LEUKOTRIENE-B4
CLAESSON HE; DAHLBERG N; GAHRTON G
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1985;60(3):429-436
PROGNOSTIC VALUE OF B-CELL MITOGEN-INDUCED AND SPONTANEOUS THYMIDINE UPTAKE INVITRO IN CHRONIC B-LYMPHOCYTIC LEUKEMIA-CELLS
JULIUSSON G; ROBERT KH; NILSSON B; GAHRTON G
Journal article: LANCET. 1985;1(8444):1503-1504
FOSCARNET FOR CYTOMEGALO-VIRUS INFECTIONS
RINGDEN O; WILCZEK H; LONNQVIST B; GAHRTON G; WAHREN B; LERNESTEDT JO
Journal article: LAKARTIDNINGEN. 1985;82(24):2239-2242
[Bone marrow transplantation at Huddinge Hospital: More and more successful therapy in malignant disease--the indications are gradually increasing].
Ringdén O; Lantz B; Bolme P; Ljungman P; Båryd I; Lundgren G; Gahrton G; Lönnqvist B; Groth CG; Möller E
Journal article: CANCER GENETICS. 1985;14(3-4):191-195
DEL(3)(P13) IN B-PROLYMPHOCYTIC LEUKEMIA - A NEW NONRANDOM CHROMOSOMAL ABERRATION POSSIBLY RELATED TO THE C-RAS ONCOGENE
JULIUSSON G; ROBERT KH; OST A; FRIBERG K; BIBERFELD P; ZECH L; GAHRTON G
Journal article: ACTA MEDICA SCANDINAVICA. 1985;217(5):553-558
LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY IN HUMAN-LEUKEMIC CELLS - RELATION TO CHROMOSOME-ABERRATIONS
LINDQUIST R; VITOLS S; GAHRTON G; OST A; PETERSON C
Journal article: ACTA MEDICA SCANDINAVICA. 1985;218(3):335-340
IMMUNE PHENOTYPE AND PROGNOSIS IN CHRONIC B-LYMPHOCYTIC LEUKEMIA AND LEUKEMIC IMMUNOCYTOMA
JULIUSSON G; OST A; BIBERFELD P; ROBERT KH; GAHRTON G
Journal article: ARCHIVES OF VIROLOGY. 1985;83(1-2):117-122
DONOR AND RECIPIENT ORIGIN OF HERPESVIRUS-REACTIVE LYMPHOCYTES AFTER BONE-MARROW TRANSPLANTATION
LJUNGMAN P; GAHRTON G; RINGDEN O; WAHREN B
Journal article: BLOOD. 1985;65(1):134-141
PROGNOSTIC INFORMATION FROM CYTOGENETIC ANALYSIS IN CHRONIC B-LYMPHOCYTIC LEUKEMIA AND LEUKEMIC IMMUNOCYTOMA
JULIUSSON G; ROBERT KH; OST A; FRIBERG K; BIBERFELD P; NILSSON B; ZECH L; GAHRTON G
Journal article: EXPERIMENTAL HEMATOLOGY. 1985;13:110
FACTORS ASSOCIATED WITH INFECTIONS AFTER BONE-MARROW TRANSPLANTATION
PAULIN T; RINGDEN O; LONNQVIST B; WAHREN B; NILSSON B; GAHRTON G
Journal article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1985;17(2):157-163
INTRAVENOUS FOSCARNET FOR THE TREATMENT OF SEVERE CYTOMEGALO-VIRUS INFECTION IN ALLOGRAFT RECIPIENTS
KLINTMALM G; LONNQVIST B; OBERG B; GAHRTON G; LERNESTEDT JO; LUNDGREN G; RINGDEN O; ROBERT KH; WAHREN B; GROTH CG
Journal article: TUMOR BIOLOGY. 1985;6(1):1-12
REVIEW - SPECIFIC CHROMOSOMAL MARKERS IN B-CELL AND T-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
GAHRTON G; JULIUSSON G; ROBERT KH; ZECH L
Journal article: BLOOD. 1985;66(2):471-472
PROGNOSTIC IMPLICATION OF TRISOMY-12 AND NON-TRISOMY-12 KARYOTYPES IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
JULIUSSON G; GAHRTON G
Journal article: ACTA HAEMATOLOGICA. 1985;74(3):171-174
PH CHROMOSOME AND B-CELL MALIGNANCY-ASSOCIATED CHROMOSOMAL-ABERRATIONS IN NONLEUKEMIC IMMUNOBLASTIC B-CELL LYMPHOMA
JULIUSSON G; FRIBERG K; GAHRTON G
Journal article: CANCER TREATMENT REPORTS. 1984;68(11):1331-1338
HUMAN-LEUKOCYTE INTERFERON AND INTERMITTENT HIGH-DOSE MELPHALAN-PREDNISONE ADMINISTRATION IN THE TREATMENT OF MULTIPLE-MYELOMA - A RANDOMIZED CLINICAL-TRIAL FROM THE MYELOMA GROUP OF CENTRAL SWEDEN
AHRE A; BJORKHOLM M; MELLSTEDT H; BRENNING G; ENGSTEDT L; GAHRTON G; GYLLENHAMMAR H; HOLM G; JOHANSSON B; JARNMARK M; KARNSTROM L; KILLANDER A; LERNER R; LOCKNER D; LONNQVIST B; NILSSON B; SIMONSSON B; STALFELT AM; STRANDER H; SVEDMYR E; WADMAN B; WEDELIN C
Journal article: TRANSPLANTATION. 1984;38(5):465-468
CYTOMEGALOVIRUS-INFECTION ASSOCIATED WITH AND PRECEDING CHRONIC GRAFT-VERSUS-HOST DISEASE
LONNQVIST B; RINGDEN O; WAHREN B; GAHRTON G; LUNDGREN G
Journal article: ACTA PSYCHIATRICA SCANDINAVICA. 1984;70(4):378-388
A RATING-SCALE FOR EMOTIONAL DISTRESS IN PATIENTS WITH MALIGNANT DISEASES
WIHOLM BE; ASBERG M; JACOBSEN K; BOMAN G; GAHRTON G
Journal article: TANDLAKARTIDNINGEN. 1984;76(19):1063-1070
[What is the treatment for acute leukemia and aplastic anemia?].
Danielsson K; Gahrton G; Heimdahl A; Liliemark J; Paul C; Ringden O
Journal article: LANCET. 1984;2(8404):693
SUCCESSFUL TREATMENT OF PURE RED-CELL APLASIA WITH CYCLOSPORIN
TOTTERMAN TH; NISELL J; KILLANDER A; GAHRTON G; LONNQVIST B
Journal article: JOURNAL OF INFECTIOUS DISEASES. 1984;150(3):358-365
Transfer and persistence of viral antibody-producing cells in bone marrow transplantation.
Wahren B; Gahrton G; Linde A; Ljungman P; Lönnqvist B; Ringdén O; Sundqvist VA
Journal article: BLOOD. 1984;63(5):1186-1193
ELEVATED LOW-DENSITY LIPOPROTEIN RECEPTOR ACTIVITY IN LEUKEMIC-CELLS WITH MONOCYTIC DIFFERENTIATION
VITOLS S; GAHRTON G; OST A; PETERSON C
Journal article: NATURE. 1984;308(5962):858-860
INVERSION OF CHROMOSOME-14 MARKS HUMAN T-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
ZECH L; GAHRTON G; HAMMARSTROM L; JULIUSSON G; MELLSTEDT H; ROBERT KH; SMITH CIE
Journal article: CANCER TREATMENT REPORTS. 1984;68(3):515-520
SIGNIFICANCE OF THE LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR PATHWAY FOR THE INVITRO ACCUMULATION OF AD-32 INCORPORATED INTO LDL IN NORMAL AND LEUKEMIC WHITE BLOOD-CELLS
VITOLS S; GAHRTON G; PETERSON C
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1984;32(3):297-305
PROGNOSTIC IMPLICATIONS OF INVITRO COLONY STUDIES AND CLONAL CHROMOSOMAL-ABERRATIONS IN ADULTS WITH ACUTE-LEUKEMIA
HORNSTEN P; LINDQUIST R; GAHRTON G
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1984;32(1):49-54
INTERFERON-ALPHA TREATMENT OF A PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND DOWNS-SYNDROME - EFFECTS ON NATURAL-KILLER CELL-ACTIVITY AND MITOGEN RESPONSIVENESS
BRATT G; EINHORN S; BLOMGREN H; GAHRTON G; PAUL C; STRANDER H
Journal article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1984;16(1):51-60
SELECTIVE DECONTAMINATION OF ALIMENTARY-TRACT MICROBIAL-FLORA IN PATIENTS TREATED WITH BONE-MARROW TRANSPLANTATION - A MICROBIOLOGICAL STUDY
HEIMDAHL A; GAHRTON G; GROTH CG; LUNDGREN G; LONNQUIST B; RINGDEN O; NORD CE
Journal article: ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY. 1984;16(1):51-60
Selective Decontamination of Alimentary Tract Microbial Flora in Patients Treated with Bone Marrow Transplantation: A Microbiological Study
Heimdahl A; Gahrton G; Groth CG; Lundgren G; Lönnquist B; Ringden O; Nord CE
Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 1983;309(25):1565-1568
MYASTHENIA-GRAVIS AFTER BONE-MARROW TRANSPLANTATION - EVIDENCE FOR A DONOR ORIGIN
SMITH CIE; AARLI JA; BIBERFELD P; BOLME P; CHRISTENSSON B; GAHRTON G; HAMMARSTROM L; LEFVERT AK; LONNQVIST B; MATELL G; PIRSKANEN R; RINGDEN O; SVANBORG E
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1983;31(1):9-14
CCNU TOXICITY AFTER AN OVERDOSE IN A PATIENT WITH HODGKINS-DISEASE - EFFECTS ON COLONY-FORMING CELLS (CFU-C) AND COLONY-STIMULATING ACTIVITY (CSA)
HORNSTEN P; SUNDMANENGBERG B; GAHRTON G; JOHANSSON B
Journal article: BLOOD. 1983;61(6):1190-1195
MARKEDLY ELEVATED SERUM IGE LEVELS FOLLOWING ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION
RINGDEN O; PERSSON U; JOHANSSON SGO; WILCZEK H; GAHRTON G; GROTH CG; LUNDGREN G; LONNQVIST B; MOLLER E
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1983;52(3):613-619
NEUTROPHIL-MEDIATED ANTIBODY-DEPENDENT CELLULAR CYTO-TOXICITY AGAINST ERYTHROCYTES - MECHANISMS OF TARGET-CELL DESTRUCTION
DALLEGRI F; PATRONE F; HOLM G; GAHRTON G; SACCHETTI C
Journal article: EUROPEAN JOURNAL OF CANCER AND CLINICAL ONCOLOGY. 1983;19(4):499-506
INTERMITTENT HIGH-DOSE MELPHALAN PREDNISONE VS CONTINUOUS LOW-DOSE MELPHALAN TREATMENT IN MULTIPLE-MYELOMA
AHRE A; BJORKHOLM M; MELLSTEDT H; HOLM G; BRENNING G; ENGSTEDT L; GAHRTON G; HALLEN J; JOHANSSON B; JOHANSSON SGO; KARNSTROM L; KILLANDER A; LERNER R; LOCKNER D; LONNQVIST B; SIMONSSON B; STALFELT AM; TERNSTEDT B; WADMAN B
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1983;17(2):109-114
OX ERYTHROCYTE CYTO-TOXICITY BY PHORBOL-MYRISTATE ACETATE-ACTIVATED HUMAN-NEUTROPHILS
DALLEGRI F; PATRONE F; BONVINI E; GAHRTON G; HOLM G; SACCHETTI C
Journal article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 1983;17(1):51-59
MITOGEN-INDUCED SWITCHING OF IMMUNOGLOBULIN HEAVY-CHAIN CLASS SECRETION IN CHRONIC LYMPHOCYTIC-B LEUKEMIA AND IMMUNOCYTOMA CELL-POPULATIONS
JULIUSSON G; ROBERT KH; HAMMARSTROM L; SMITH CIE; BIBERFELD G; GAHRTON G
Journal article: TRANSPLANTATION PROCEEDINGS. 1983;15(1):1490-1494
EARLY DIAGNOSIS AND TREATMENT OF ACUTE HUMAN GRAFT-VERSUS-HOST DISEASE
RINGDEN O; PERSSON U; GUNNAR S; JOHANSSON O; GAHRTON G; GROTH CG; LUNDGREN G; LONNQVIST B
Journal article: ACTA RADIOLOGICA ONCOLOGY. 1983;22(6):423-428
INCREASED MORTALITY BY SEPTICEMIA, INTERSTITIAL PNEUMONITIS AND PULMONARY FIBROSIS AMONG BONE-MARROW TRANSPLANT RECIPIENTS RECEIVING AN INCREASED MEAN DOSE-RATE OF TOTAL IRRADIATION
RINGDEN O; BARYD I; JOHANSSON B; GAHRTON G; GROTH CG; LUNDGREN G; LONNQVIST B
Journal article: EXPERIMENTAL HEMATOLOGY. 1983;11:131-133
INCREASED MORTALITY IN BONE-MARROW TRANSPLANT RECIPIENTS ACCIDENTALLY RECEIVING AN INCREASED DOSE-RATE OF TOTAL-BODY IRRADIATION
RINGDEN O; BARYD I; JOHANSSON B; BOLME P; GAHRTON G; GROTH CG; KLINTMALM G; LUNDGREN G; LONNQVIST B
Journal article: MECHANISMS AND THERAPY OF LIVER CANCER. 1983;40:255-329
TREATMENT OF ACUTE-LEUKEMIA - ADVANCES IN CHEMOTHERAPY, IMMUNOTHERAPY, AND BONE-MARROW TRANSPLANTATION
GAHRTON G
Journal article: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1983;417:344-358
NCA: a differentiation antigen of myelopoietic cells in humans and hominoid monkeys.
Wahren B; Gadler F; Gahrton G; Hammarström S; Hareland Y; Hydén N; Ljungdahl E; Måhlén A; Rudén U; Wiklund M
Journal article: EUROPEAN JOURNAL OF CANCER AND CLINICAL ONCOLOGY. 1982;18(11):1117-1123
TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND WELL-DIFFERENTIATED LYMPHOCYTIC LYMPHOMA WITH CONTINUOUS LOW-DOSE OR INTERMITTENT HIGH-DOSE PREDNIMUSTINE VERSUS CHLORAMBUCIL PREDNISOLONE
IDESTROM K; KIMBY E; BJORKHOLM M; MELLSTEDT H; ENGSTEDT L; GAHRTON G; JOHANSSON B; KILLANDER D; ROBERTS KH; STALFELT AM; UDEN AM; WADMAN B; WAHLBY S
Journal article: NATURE. 1982;297(5866):513-514
CYTOGENETIC MAPPING OF THE DUPLICATED SEGMENT OF CHROMOSOME-12 IN LYMPHOPROLIFERATIVE DISORDERS
GAHRTON G; ROBERT KH; FRIBERG K; JULIUSSON G; BIBERFELD P; ZECH L
Journal article: CANCER GENETICS. 1982;6(2):171-181
CHROMOSOMAL-ABERRATIONS IN CHRONIC B-CELL LYMPHOCYTIC-LEUKEMIA
GAHRTON G; ROBERT KH
Journal article: TRANSPLANTATION. 1982;33(5):500-504
EXPERIENCE WITH A COOPERATIVE BONE-MARROW TRANSPLANTATION PROGRAM IN STOCKHOLM
RINGDEN O; LONNQVIST B; LUNDGREN G; GAHRTON G; GROTH CG; MOLLER E; BARYD I; JOHANSSON B; PHILSTEDT P; GULLBRING B
Journal article: INTERNATIONAL JOURNAL OF CANCER. 1982;29(2):133-137
CLINICAL-EVALUATION OF NCA IN PATIENTS WITH CHRONIC MYELOCYTIC-LEUKEMIA
WAHREN B; GAHRTON G; RUDEN U; HAMMARSTROM S
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1982;28(2):163-168
EXTRA CHROMOSOME-12 AND PROGNOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA
ROBERT KH; GAHRTON G; FRIBERG K; ZECH L; NILSSON B
Journal article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 1982;47(2):414-418
ANTIBODY-DEPENDENT CELLULAR CYTO-TOXICITY OF LEUKEMIC BLAST CELLS AND NEUTROPHILS FROM PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
DALLEGRI F; HOLM G; GAHRTON G
Journal article: ACTA MEDICA SCANDINAVICA. 1982;211(3):195-201
INVITRO COLONY STUDIES IN 87 PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA - PROGNOSTIC VALUE OF COLONY-STIMULATING ACTIVITY AND COLONY-FORMING CELLS
HORNSTEN P; GAHRTON G; SUNDMAN B; WAHREN B
Journal article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 1982;9(2):89-92
PREDNIMUSTINE AND VINCRISTINE COMPARED WITH CYTOSINE-ARABINOSIDE AND THIOGUANINE FOR TREATMENT OF ELDERLY PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA
LONNQVIST B; ANDERSSON B; BJORKHOLM M; ENGSTEDT L; GAHRTON G; HAST R; HOLM G; KILLANDER A; LANTZ B; LOCKNER D; MELLSTEDT H; PALMBLAD J; PAUL C; PETERSON C; SIMONSSON B; STALFELT AM; UDEN AM; WADMAN B; OBERG G
Journal article: EXPERIMENTAL HEMATOLOGY. 1982;10:94-95
CORRELATION BETWEEN INCREASE IN SERUM-IGE LEVELS AND CLINICAL SIGNS OF ACUTE GRAFT-VERSUS-HOST DISEASE
RINGDEN O; PERSSON U; JOHANSSON G; GAHRTON G; GROTH CG; KLINTMALM G; LUNDGREN G; LONNQVIST B; MOLLER E
Journal article: CANCER. 1981;48(7):1531-1534
REDUCING THE CARDIOTOXICITY OF ANTHRACYCLINES BY COMPLEX-BINDING TO DNA - REPORT OF 3 CASES
PAUL C; LONNQVIST B; GAHRTON G; LOCKNER D; PETERSON C
Journal article: BLOOD. 1981;58(4):859
INCIDENCE OF SPECIFIC CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
Gahrton G; Robert K-H; Zech L
Journal article: BLOOD. 1981;58(4):859
Incidence of specific chromosomal aberrations in chronic lymphocytic leukemia.
Gahrton G; Robert KH; Zech L
Journal article: JOURNAL OF STEROID BIOCHEMISTRY. 1981;14(8):757-764
QUANTITATION OF THE CYTOSOLIC GLUCOCORTICOID RECEPTOR IN HUMAN NORMAL AND NEOPLASTIC LEUKOCYTES USING ISOELECTRIC-FOCUSING IN POLYACRYLAMIDE-GEL
HANSSON LA; GUSTAFSSON SA; CARLSTEDTDUKE J; GAHRTON G; HOGBERG B; GUSTAFSSON JA
Journal article: JOURNAL OF INTERNAL MEDICINE. 1981;209(1‐6):10
Immunobiology of Bone Marrow Transplantation
Gahrton G
Journal article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 1981;6(1):65-73
COMPARISON OF DAUNORUBICIN AND DAUNORUBICIN-DNA COMPLEX IN THE TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA
PAUL C; BJORKHOLM M; CHRISTENSON I; ENGSTEDT L; GAHRTON G; HAST R; HOLM G; KILLANDER A; LANTZ B; LOCKNER D; LONNQVIST B; MELLSTEDT H; PALMBLAD J; PETERSON C; SIMONSSON B; STALFELT AM; UDEN AM; WADMAN B; OBERG G
Journal article: SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, SUPPLEMENT. 1981;64:238-245
BONE-MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA AND ACUTE-LEUKEMIA AT HUDDINGE-HOSPITAL
RINGDEN O; BLOM B; COLLSTE H; GAHRTON G; GROTH CG; GRIMFORS G; HEIMDAHL A; LUNDGREN G; LONNQVIST B; MOLLER E; PIHLSTEDT P
Journal article: BLOOD. 1980;56(4):640-647
NON-RANDOM CHROMOSOMAL-ABERRATIONS IN CHRONIC LYMPHOCYTIC-LEUKEMIA REVEALED BY POLYCLONAL B-CELL-MITOGEN STIMULATION
GAHRTON G; ROBERT KH; FRIBERG K; ZECH L; BIRD AG
Journal article: CANCER LETTERS. 1980;9(4):263-269
DETERMINATION OF DAUNORUBICIN AND ITS MAIN METABOLITES IN PLASMA, URINE AND LEUKEMIC-CELLS IN PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA
PAUL C; BAURAIN R; GAHRTON G; PETERSON C
Journal article: CANCER RESEARCH. 1980;40(6):2039-2044
NONSPECIFIC CROSS-REACTING ANTIGEN IN NORMAL AND LEUKEMIC MYELOID CELLS AND SERUM OF LEUKEMIC PATIENTS
WAHREN B; GAHRTON G; HAMMARSTROM S
Journal article: LANCET. 1980;1(8160):146-147
EXTRA CHROMOSOME-12 IN CHRONIC LYMPHOCYTIC-LEUKEMIA
GAHRTON G; ROBERT KH; FRIBERG K; ZECH L; BIRD AG
Journal article: ACTA MEDICA SCANDINAVICA. 1980;207(1):97-103
CLINICAL-SIGNIFICANCE OF MITOGEN-INDUCED RESPONSES IN LYMPHOCYTES FROM PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA
ROBERT KH; GAHRTON G; MOLLER E; NILSSON B
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1980;24(1):42-46
2 TRANSLOCATIONS, T(11-14) AND T(1-6), IN A PATIENT WITH PLASMA-CELL LEUKEMIA AND 2 POPULATIONS OF PLASMA-CELLS
GAHRTON G; ZECH L; NILLSSON K; LONNQVIST B; CARLSTROM A
Journal article: NEW ENGLAND JOURNAL OF MEDICINE. 1979;301(8):438-439
MITOGENIC STIMULATION OF LEUKEMIA-CELLS BY EPSTEIN-BARR VIRUS
GAHRTON G; ZECH L; ROBERT KH; BIRD AG
Journal article: HUMAN GENETICS. 1979;49(2):225-227
TRANSLOCATION BETWEEN CHROMOSOME 7 AND CHROMOSOME 22, T(7-22)(P22-Q12), IN A PATIENT WITH CHRONIC MYELOCYTIC-LEUKEMIA
GAHRTON G; FRIBERG K; ZECH L
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1979;22(4):333-338
SUCCESSFUL TREATMENT WITH PREDNISONE OF GRAFT VERSUS HOST DISEASE IN AN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENT
GROTH CG; GAHRTON G; LUNDGREN G; MOLLER E; PIHLSTEDT P; RINGDEN O; SUNDELIN P
Journal article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 1979;2(1):1
Introduction
Gahrton G; Killander A; Peterson C
Journal article: ACTA MEDICA SCANDINAVICA. 1979;206(4):321-325
ISOCHROMOSOME-17 IN A PATIENT WITH A MYELOPROLIFERATIVE DISORDER TERMINATING IN EOSINOPHILIC LEUKEMIA
LONNQVIST B; GAHRTON G; ERIKSSON P; FRIBERG K; ZECH L
Journal article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 1979;2(1):73-76
TREATMENT OF ACUTE NONLYMPHOBLASTIC LEUKEMIA IN ADULTS WITH DAUNORUBICIN-DNA COMPLEX - PRELIMINARY-REPORT
GAHRTON G; BJORKHOLM M; BRENNING G; CHRISTENSON I; ENGSTEDT L; FRANZEN S; GULLBRING B; HOLM G; HOGMAN C; HORNSTEN P; JAMESON S; KILLANDER A; SIMONSSONLINDEMALM C; LOCKNER D; LONNQVIST B; MELLSTEDT H; PALMBLAD J; PAUL C; PAULI C; PETERSON C; REIZENSTEIN P; SIMONSSON B; SKARBERG KO; UDEN AM; WADMAN B
Journal article: CANCER CHEMOTHERAPY AND PHARMACOLOGY. 1979;2(1):49-52
UPTAKE OF FREE AND DNA-BOUND DAUNORUBICIN AND DOXORUBICIN INTO HUMAN-LEUKEMIC CELLS
PAUL C; PETERSON C; GAHRTON G; LOCKNER D
Journal article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 1978;4(3):179-183
ADJUVANT IMMUNOTHERAPY IN ACUTE NONLYMPHOCYTIC LEUKEMIA
LINDEMALM CS; KILLANDER A; BJORKHOLM M; BRENNING G; ENGSTEDT L; FRANZEN S; GAHRTON G; GULLBRING B; HOLM G; HOGLUND S; HORNSTEN P; JAMESON S; KILLANDER D; KLEIN E; LANTZ B; LOCKNER D; LONNQVIST B; MELLSTEDT H; PALMBLAD J; PAULI C; REIZENSTEIN P; SIMONSSON B; SKARBERG KO; UDEN AM; VANKY F; WADMAN B
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1978;21(2):109-114
TRISOMY-8 IN CHRONIC PHASE OF PHILADELPHIA NEGATIVE CHRONIC MYELOCYTIC-LEUKEMIA
LINDQUIST R; GAHRTON G; FRIBERG K; ZECH L
Journal article: LANCET. 1978;1(8055):96-97
DUPLICATION OF PART OF CHROMOSOME NO-1 IN MYELOPROLIFERATIVE DISEASES
GAHRTON G; FRIBERG K; ZECH L; LINDSTEN J
Journal article: HEREDITAS. 1978;89(2):169-173
CONSTITUTIONAL CHROMOSOMAL ABERRATION, T(4-12)(Q23-P11), IN A PATIENT WITH PH1 POSITIVE CHRONIC MYELOCYTIC-LEUKEMIA
GAHRTON G; FRIBERG K; ZECH L
Journal article: HEREDITAS. 1978;88(1):1-5
DUPLICATION OF PART OF LONG ARM OF CHROMOSOME 1 IN MYELOFIBROSIS TERMINATING IN ACUTE MYELOBLASTIC-LEUKEMIA
GAHRTON G; FRIBERG K; LINDSTEN J; ZECH L
Journal article: ACTA MEDICA SCANDINAVICA. 1977;201(5):405-410
Prognostic value of colony-stimulating and colony-forming cells in peripheral blood in acute non-lymphoblastic leukemia.
Hörnsten P; Granström M; Wahren B; Gahrton G
Journal article: CYTOGENETIC AND GENOME RESEARCH. 1977;18(2):75-81
NEW TRANSLOCATION INVOLVING 3 CHROMOSOMES IN CHRONIC MYELOCYTIC-LEUKEMIA, 46,XY,T(9,11,22)
GAHRTON G; FRIBERG K; ZECH L
Journal article: CANCER. 1976;37(1):220-228
HYPERSENSITIVE REACTIONS AND ANTIBODY-FORMATION DURING L-ASPARAGINASE TREATMENT OF CHILDREN AND ADULTS WITH ACUTE-LEUKEMIA
KILLANDER D; DOHLWITZ A; ENGSTEDT L; FRANZEN S; GAHRTON G; GULLBRING B; HOLM G; HOLMGREN A; HOGLUND S; KILLANDER A; LOCKNER D; MELLSTEDT H; MOE PJ; PALMBLAD J; REIZENSTEIN P; SKARBERG KO; SWEDBERG B; UDEN AM; WADMAN B; WIDE L; AHSTROM L
Journal article: HEREDITAS. 1976;84(1):15-18
CHROMOSOMAL SATELLITES AS MARKERS IN HUMAN BONE-MARROW TRANSPLANTATION
GAHRTON G; ZECH L; FRIBERG K; LUNDGREN G; MOLLER E; GROTH CG
Journal article: PROGRESS IN HISTOCHEMISTRY AND CYTOCHEMISTRY. 1976;9(1):iii-29
Quantitative cytochemistry of glycogen in blood cells. Methods and clinical application.
Gahrton G; Yataganas X
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1975;15(4):251-255
MONOSOMY 7 IN 2 ADULT PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
ZECH L; LINDSTEN J; UDEN AM; GAHRTON G
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1975;15(1):72-80
L-ASPARAGINASE AND PREDNISOLONE PRETREATMENT FOLLOWED BY RUBIDOMYCIN AND CYTOSINE-ARABINOSIDE FOR INDUCTION OF REMISSION IN ADULT PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
UDEN AM; BRENNING G; ENGSTEDT L; FRANZEN S; GAHRTON G; GULLBRING B; HOLM G; HOGLUND S; JAMESON S; KILLANDER A; KILLANDER D; LOCKNER D; MELLSTEDT H; PALMBLAD J; REIZENSTEIN P; SKARBERG KO; SWEDBERG B; WADMAN B; WIDE L
Journal article: JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 1975;23(1):59-64
DETERMINATION OF GLYCOGEN CONTENT IN SINGLE NEUTROPHIL LEUKOCYTES USING A MICROMODEL OF LEUKOCYTE GLYCOGEN
GAHRTON G; OLSSON I; DAHLQVIST A
Journal article: CANCER. 1974;34(2):472-479
Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
Journal article: BLOOD. 1974;43(6):837-840
Clonal origin of the Philadelphia chromosome from either the paternal or the maternal chromosome number 22.
Gahrton G; Lindsten J; Zech L
Journal article: EXPERIMENTAL CELL RESEARCH. 1974;86(1):214-216
A new variant translocation (19q plus, 22q minus) in chronic myelocytic leukemia.
Gahrton G; Zech L; Lindsten J
Journal article: BLOOD. 1974;43(4):557-563
Trisomy 8 in acute myeloblastic leukemia and sideroachrestic anemia.
Jonasson J; Gahrton G; Lindsten J; Simonsson-Lindemalm C; Zech L
Journal article: BLOOD. 1974;43(2):243-250
Intranuclear hemoglobin in erythroblasts of beta-thalassemia.
Yataganas X; Gahrton G; Thorell B
Journal article: ACTA MEDICA SCANDINAVICA. 1974;196(3):221-226
Colony-forming and colony-stimulating cells in relation to prognosis in leukemia.
Granström M; Gahrton G
Journal article: ACTA MEDICA SCANDINAVICA. 1974;196(5):355-360
Involvement of chromosomes 8, 9, 19 and 22 in PH1 positive and PH1 negative chronic myelocytic leukemia in the chronic or blastic stage.
Gahrton G; Lindsten J; Zech L
Journal article: ACTA MEDICA SCANDINAVICA. 1974;196(5):353-354
Editorial: The Philadelphia chromosome and chronic myelocytic leukemia (CML) --still a complex relationship?
Gahrton G; Lindsten J; Zech L
Journal article: EXPERIMENTAL CELL RESEARCH. 1973;80(2):372-376
Colony-forming and colony-stimulating cells in normal human peripheral blood.
Granström M; Gahrton G
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1973;24(5):651-659
Proliferative activity and glycogen accumulation of erythroblasts in -thalassaemia.
Yataganas X; Gahrton G; Fessas P; Kesse-Elias M; Thorell B
Journal article: EXPERIMENTAL CELL RESEARCH. 1973;79(1):246-247
Origin of the Philadelphia chromosome. Tracing of chromosome 22 to parents of patients with chronic myelocytic leukemia.
Gahrton G; Lindsten J; Zech L
Journal article: EXPERIMENTAL EYE RESEARCH. 1973;79(1):246-247
Origin of the Philadelphia chromosome. Tracing of chromosome 22 to parents of patients with chronic myelocytic leukemia.
Gahrton G; Lindsten J; Zech L
Journal article: INTERNATIONAL JOURNAL OF CANCER. 1972;10(3):482-488
Inhibitors of the bone-marrow colony formation in sera of patients with leukemia.
Granström M; Wahren B; Gahrton G; Killander D; Foley GE
Journal article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1972;2(6):412-416
Cytochemical population analyses of glycogen in neutrophil leukocytes of chronic myelocytic leukaemia during busulfan treatment.
Gahrton G; Zetterberg A
Journal article: BRITISH JOURNAL OF HAEMATOLOGY. 1972;22(2):117-123
Quantification of -chain excess in erythrocytes in -thalassaemia by microinterferometry.
Yataganas X; Fessas P; Gahrton G
Journal article: ACTA HAEMATOLOGICA. 1972;48(4):227-233
Influence of cell density on the acridine orange binding to deoxyribonucleoprotein complex in leucocytes from patients with infectious mononucleosis and acute leukaemia.
Bolund L; De Bault LE; Foley GE; Gahrton G; Killander D; Moloney WC; Rigler R; Skarin A; Wahren B
Journal article: INTERNATIONAL JOURNAL OF CANCER. 1971;8(2):242-249
Epstein-Barr and other herpes virus antibodies in children with acute leukemia.
Gahrton G; Wahren B; Killander D; Foley GE
Journal article: EXPERIMENTAL CELL RESEARCH. 1971;65(1):156-160
Cytochemical population analysis of cell linesderived from Burkitt's lymphoma, infectious mononucleosis, and acute lymphoblastic leukemia.
De Bault L; Gahrton G; Foley GE
Journal article: EXPERIMENTAL CELL RESEARCH. 1970;63(1):238-240
Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis.
Caspersson T; Gahrton G; Lindsten J; Zech L
Journal article: EXPERIMENTAL CELL RESEARCH. 1970;62(1):254-261
DNA, RNA and hemoglobin during erythroblast maturation. A cytophotometric study.
Yataganas X; Gahrton G; Thorell B
Journal article: BLOOD. 1970;35(3):322-332
Structural changes in the deoxyribonucleoprotein (DNP) complex of leukocytes from patients with infectious mononucleosis.
Bolund L; Gahrton G; Killander D; Rigler R; Wahren B
Journal article: EXPERIMENTAL CELL RESEARCH. 1969;56(1):59-68
Microspectrofluorometry of a periodic acid-schiff reaction in blood cells.
Yataghanas X; Gahrton G; Thorell B
Journal article: SCANDINAVIAN JOURNAL OF HAEMATOLOGY. 1969;6(6):365-372
Cytochemical variants of neutrophil leukocyte populations in chronic myelocytic leukaemia. A microspectrophotometric study of the change in the periodic acid-Schiff (PAS) reaction in blood and bone marrow neutrophils during busulfan treatment.
Gahrton G; Brandt L; Franzén S; Nordén A
Journal article: BLOOD. 1966;28(4):544-552
The periodic acid-Schiff reaction in neutrophil leukocytes in untreated and myleran-treated chronic myelocytic leukemia. A quantitative microspectrophotometric study.
Gahrton G
Journal article: EXPERIMENTAL CELL RESEARCH. 1966;43(3):564-570
Cytochemical population analyses of continuous cultures of human lymphoblasts derived from acute lymphoblastic leukemia.
McCarthy RE; Gahrton G; Farber S; Foley GE
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1966;3(2):106-116
The Periodic Acid‐Schiff Reaction in Neutrophil Leukocytes in Chronic Myeloproliferative Diseases A microspectrophotometric study
Gahrton G
Journal article: EXPERIMENTAL CELL RESEARCH. 1966;42(2):218-229
A quantitative cytochemical investigations of DNA, RNA and protein in lymphoid cells from normal, preleukemic and leukemic mice.
Gahrton G; Habicht W; Wahren B
Journal article: ACTA MEDICA SCANDINAVICA. 1966;180(4):497-500
Glycogen synthesis in normal, leukemic and polycythemic leukocytes. Preliminary report of a quantitative cytochemical study.
Gahrton G; Zetterberg A
Journal article: ACTA MEDICA SCANDINAVICA. 1966;180(4):485-496
Cytochemical population analyses of the DNA, RNA and protein content of human leukemic cells.
Gahrton G; Foley GE
Journal article: JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 1966;14(1):45-48
Normal human neutrophil leukocytes as a reference system for the microspectrophotometrically quantitated periodic acid-Schiff reaction.
Gahrton G
Journal article: HISTOCHEMIE. HISTOCHEMISTRY. HISTOCHIMIE. 1966;6(2):112-119
The periodic acid-Schiff reaction in neutrophil leukocytes--influence of fixation and amylase digestion. A quantitative microspectrophotometric study.
Gahrton G
Journal article: EUROPEAN JOURNAL OF CANCER. 1965;1(3):299-302
A quantified periodic acid-Schiff reaction in normal and leukemic leukocytes.
Gahrton G
Journal article: EXPERIMENTAL CELL RESEARCH. 1964;34:488-506
MICROSPECTROPHOTOMETRIC QUANTITATION OF THE PERIODIC ACID-SCHIFF (PAS) REACTION IN HUMAN NEUTROPHIL LEUKOCYTES BASED ON A MODEL SYSTEM OF GLYCOGEN MICRODROPLETS.
GAHRTON G
Journal article: ACTA MEDICA SCANDINAVICA. 1963;174:105-114
SERUM VITAMIN B12 DETERMINATIONS AND CYTOCHEMICAL REACTIONS IN THE DIFFERENTIAL DIAGNOSIS OF ACUTE LEUKAEMIA.
OLSSON I; GAHRTON G; NORDEN A
Journal article: ACTA MEDICA SCANDINAVICA. 1962;171:243-249
Cytochemical investigations and serum vitamin B12 determinations in a case of erythroleukaemia.
GAHRTON G; NORDEN A; STAHLBERG KG
Journal article: ACTA MEDICA SCANDINAVICA. 1962;172:31-40
The content of total and acid-soluble glycogen in the white blood cells and its relation to the staining with the periodic acid-Schiff reagents.
DAHLQVIST A; GAHRTON G; NORDEN A
Journal article: JOURNAL OF INTERNAL MEDICINE. 1961;170(4):431-438
EGG Changes in Pectus Excavatum (Funnel Chest)
Gahrton G
Visa fler

Alla övriga publikationer

Conference publication: BLOOD. 2024;144(Supplement 1):3318
A Lightweight Risk Scoring System for Stratification of Newly Diagnosed Multiple Myeloma Patients
Riga G; Luong V; Uttervall K; Gahrton G; Nahi H; Lund J; Alici E; Kashif M
Book: 2024
In the Shadow of the Nobel Prize
Gahrton G
Review: LANCET ONCOLOGY. 2024;25(5):e205-e216
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Rodriguez-Otero P; Usmani S; Cohen AD; van de Donk NWCJ; Leleu X; Gállego Pérez-Larraya J; Manier S; Nooka AK; Mateos MV; Einsele H; Minnema M; Cavo M; Derman BA; Puig N; Gay F; Ho PJ; Chng W-J; Kastritis E; Gahrton G; Weisel K; Nagarajan C; Schjesvold F; Mikhael J; Costa L; Raje NS; Zamagni E; Hájek R; Weinhold N; Yong K; Ye JC; Sidhana S; Merlini G; Martin T; Lin Y; Chari A; Popat R; Kaufman JL; International Myeloma Working Group
Meeting abstract: BLOOD. 2023;142:1960
A Novel Biosignature for Potential Stratification and Elucidation of Newly Diagnosed Multiple Myeloma Patients at-Risk
Kashif M; Zhou Y; Luong V; Uttervall K; Gahrton G; Nahi H; Alici E; Lund J
Editorial comment: HAEMATOLOGICA. 2023;108(10):2568-2569
CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?
Gahrton G
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225
Response to Caravita di Toritto and Rago
Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Conference publication: BLOOD. 2022;140:2126-2129
Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study
Niederwieser D; Hasenclever D; Berdel WE; Biemond BJ; Al-Ali HK; Chalandon Y; Van Gelder M; Junghanss C; Gahrton G; Haenel M; Hehlmann R; Heinicke T; Hochhaus A; Iacobelli S; Kooy RVM; Kroger N; Janssen JJWM; Jentzsch M; Breywisch F; Mohty M; Masouridi-Levrat S; Ossenkoppele G; Passweg J; Poenisch W; Schetelig J; Schliemann C; Schwind S; Stelljes M; Valk PJM; Lowenberg B; Cornelissen JJ
Meeting abstract: BLOOD. 2021;138:4796
CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion
Nahi H; Chrobook M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Walther-Jallow L; Liwing J; Klimkowska M; Gahrton G; Ljungman P; Ljunggren H-G; Alici E
Review: BRITISH JOURNAL OF HAEMATOLOGY. 2021;194(3):496-507
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Rosinol L; Beksac M; Zamagni E; Van de Donk NWCJ; Anderson KC; Badros A; Caers J; Cavo M; Dimopoulos M-A; Dispenzieri A; Einsele H; Engelhardt M; Fernandez de Larrea C; Gahrton G; Gay F; Hajek R; Hungria V; Jurczyszyn A; Kroeger N; Kyle RA; Leal da Costa F; Leleu X; Lentzsch S; Mateos MV; Merlini G; Mohty M; Moreau P; Rasche L; Reece D; Sezer O; Sonneveld P; Usmani SZ; Vanderkerken K; Vesole DH; Waage A; Zweegman S; Richardson PG; Blade J
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2020;26(9):1559-1566
Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT
Garderet L; Morris C; Beksac M; Gahrton G; Schoenland S; Yakoub-Agha I; Hayden PJ
Review: JOURNAL OF CLINICAL MEDICINE. 2020;9(7):E2180-2180
Allogeneic Transplantation in Multiple Myeloma-Does It Still Have a Place?
Gahrton G; Iacobelli S; Garderet L; Yakoub-Agha I; Schoenland S
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(5):e213-e217
Treosulfan conditioning for allogeneic transplantation in multiple myeloma - improved overall survival in first line haematopoietic stem cell transplantation - a large retrospective study by the Chronic Malignancies Working Party of the EBMT
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Einsele H; Niittyvoupio R; Edinger M; Beelen D; Ciceri F; Bornhaeuser M; Finke J; de Wreede LC; Ljungman P; Mielke S; Tischer J; Garderet L; Schoenland S; Yakoub-Agha I; Kroeger N
Conference publication: BLOOD. 2019;134:259
Tandem Autologous-Autologous Vs. Autologous-Allogeneic Transplantation for Newly Diagnosed Multiple Myeloma: Pooled Analysis of 1,338 Patients from Four Trials with Long-Term Follow up
Costa LJ; Iacobelli S; Pasquini MC; Modi R; Giaccone L; Blade J; Schonland S; Evangelista A; Perez-Simon JA; Hari P; Brown EE; Giralt SA; Patriarca F; Stadtmauer EA; Rosinol L; Krishnan AY; Gahrton G; Bruno B
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E206
Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma - Improved Overall Survival in first line Hematopoietic Stem Cell Transplantation
Gran C; Wang J; Nahi H; Koster L; Gahrton G; Wolschke C; Einsele H; Niittyvoupio R; Blaise D; Niederwieser D; Meier E; Petersen E; de Wreede LC; Ljungman P; Bourhis JH; Veelken H; Beelen D; Stelljes M; Gerbitz A; Vincent L; Finke J; Passweg J; Milpied N; Stoelzel F; Yakoub-Agha I; Schoenland S; Garderet L; Kroger N
Meeting abstract: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2019;19(10):E170
Novel RNA construct increases cytotoxic proteins in lymphocytes and leads to prolonged survival in an experimental syngeneic immunocompetent Multiple Myeloma model
Wagner AK; Baloch AH; Chrobok M; Dahlberg C; Gahrton G; Nahi H; Ljunggren H-G; Alici E
Conference publication: BONE MARROW TRANSPLANTATION. 2018;53:659-660
Treosulfan conditioning for allogenic hematopoietic stem cell transplantation in multiple myeloma, advantages for non-relapse mortality and survival, but with high incidence of relapse
Gran C; Wang J; Nahi H; Koster L; Einsele H; Itala-Remes M; Holler E; Beelen D; Ciceri F; Ehninger G; Finke J; de Wreede L; Ljungman P; Tischer J; Verbeek M; Klyuchnikov E; Hilgendorf I; Schaefer-Eckart K; Scheid C; Bunjes D; Basara N; Haenel M; Mueller LP; Biersack H; Gahrton G; Garderet L; Kroeger N
Editorial comment: LANCET HAEMATOLOGY. 2017;4(6):e250-e251
Gemcitabine, busulfan, and melphalan conditioning for autologous stem-cell transplants in multiple myeloma
Gahrton G
Review: LEUKEMIA & LYMPHOMA. 2016;57(6):1256-1268
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)
Bruno B; Auner HW; Gahrton G; Garderet L; Festuccia M; Ladetto M; Lemoli RM; Massaia M; Morris C; Palumbo A; Schoenland S; Boccadoro M; Kroeger N
Review: LEUKEMIA. 2016;30(5):1005-1017
Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group
Laubach J; Garderet L; Mahindra A; Gahrton G; Caers J; Sezer O; Voorhees P; Leleu X; Johnsen HE; Streetly M; Jurczyszyn A; Ludwig H; Mellqvist U-H; Chng W-J; Pilarski L; Einsele H; Hou J; Turesson I; Zamagni E; Chim CS; Mazumder A; Westin J; Lu J; Reiman T; Kristinsson S; Joshua D; Roussel M; O'Gorman P; Terpos E; McCarthy P; Dimopoulos M; Moreau P; Orlowski RZ; Miguel JS; Anderson KC; Palumbo A; Kumar S; Rajkumar V; Durie B; Richardson PG
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S592
Treosulfan plus fludarabine - encouraging conditioning for allogeneic hematopoietic stem cell transplantation in multiple myeloma
Afram G; Nahi H; Liwing J; Heeg B; Mattsson J; LeBlanc K; Bjorkstrand B; Gahrton G; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S108-S109
Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Evolution and Outcomes over More Than Two Decades within EBMT Centers
Michallet M; Sobh M; Iacobelli S; Van Biezen A; Dreger P; Petersen E; Schaap M; Bandini G; Volin L; Meijer E; Niederwieser D; Einsele H; Blaise D; Tabrizi R; Vincent L; Finke J; Bunjes D; Cornelissen J; Gahrton G; Garderet L; Kroeger N
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S17
Multiple Myeloma patients with del(8)(p21) are more resistant to Bortezomib treatment
Duru AD; Sutlu T; Wallblom A; Uttervall K; Lund J; Stellan B; Gahrton G; Nahi H; Alici E
Conference publication: BLOOD. 2014;124(21):2554
Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Evolution and Outcomes over More Than Two Decades within EBMT Centers
Michallet M; Sobh M; Iacobelli S; van Biezen A; Dreger P; Petersen E; Schaap NPM; Bandini G; Volin L; Meijer E; Niederwieser D; Einsele H; Blaise D; Tabrizi R; Vincent L; Finke J; Bunjes D; Cornelissen JJ; Gahrton G; Garderet L; Kroger N
Review: LEUKEMIA. 2014;28(2):269-277
IMWG consensus on risk stratification in multiple myeloma
Chng WJ; Dispenzieri A; Chim C-S; Fonseca R; Goldschmidt H; Lentzsch S; Munshi N; Palumbo A; Miguel JS; Sonneveld P; Cavo M; Usmani S; Durie BGM; Avet-Loiseau H
Review: EXPERT REVIEW OF HEMATOLOGY. 2014;7(1):79-90
Allogeneic transplantation in multiple myeloma
Gahrton G; Krishnan A
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S79
REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA: A COMPARISON OF TANDEM AUTO-ALLOGRAFT TO EARLY REDUCED INTENSITY ALLOGRAFT AS UPFRONT TRANSPLANT: AN EBMT ANALYSIS ON BEHALF OF THE PLASMA CELL DISORDERS
Sahebi F; Iacobelli S; Van Biezen A; Volin L; Dreger P; Michallet M; Ljungman PT; Morris CTCM; Schonland S; de Witte T; Garderet L; Henseler A; Schaap NPM; Lopez-Corral L; Poire X; Passweg J; Hamljadi RM; Kroeger N; Gahrton G
Meeting abstract: BLOOD. 2013;122(21):920
Reduced Intensity Allogeneic Stem Cell Transplant In Patients With Multiple Myeloma: A Comparison Of Planned Autologous-Reduced Intensity Allogeneic Stem Cell Transplant (Auto-Allo) and Reduced Intensity Allogeneic Stem Cell Transplant (RIC) As Upfront Transplant In Patients With Multiple Myeloma, An EBMT Analysis
Sahebi F; Iacobelli S; Van Biezen A; Volin L; Dreger P; Michallet M; Ljungman PT; Gahrton G; Morris CTCM; Schonland S; de Witte T; Garderet L; Kroeger N; Henseler A; Schaap NPM; Caballero D; Poire X; Passweg J; Hamljadi R-M
Review: LEUKEMIA. 2013;27(4):780-791
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Fernandez de Larrea C; Kyle RA; Durie BGM; Ludwig H; Usmani S; Vesole DH; Hajek R; San Miguel JF; Sezer O; Sonneveld P; Kumar SK; Mahindra A; Comenzo R; Palumbo A; Mazumber A; Anderson KC; Richardson PG; Badros AZ; Caers J; Cavo M; Leleu X; Dimopoulos MA; Chim CS; Schots R; Noeul A; Fantl D; Mellqvist U-H; Landgren O; Chanan-Khan A; Moreau P; Fonseca R; Merlini G; Lahuerta JJ; Blade J; Orlowski RZ; Shah JJ
Letter: MEDICAL ONCOLOGY. 2013;30(2):569
In search of the molecular consequences of 8p21 deletion in multiple myeloma: commentary on Gmidene et al
Sutlu T; Alici E; Gahrton G; Nahi H
Book chapter: THE CLINIBOOK. 2012;p. 201-207
A4-4 Genetically modified NK cells for cancer treatment: facts and visions
Alici E; Gahrton G
Published conference paper: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(20):2475-2482
Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Garderet L; Iacobelli S; Moreau P; Dib M; Lafon I; Niederwieser D; Masszi T; Fontan J; Michallet M; Gratwohl A; Milone G; Doyen C; Pegourie B; Hajek R; Casassus P; Kolb B; Chaleteix C; Hertenstein B; Onida F; Ludwig H; Ketterer N; Koenecke C; van Os M; Mohty M; Cakana A; Gorin NC; de Witte T; Harousseau JL; Morris C; Gahrton G
Letter: CANCER GENETICS. 2012;205(6):338-339
Historical note on the discovery of the Philadelphia chromosome
Gahrton G
Other: MOLECULAR THERAPY. 2012;20(6):1084-1094
Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy
Corrigan-Curay J; Cohen-Haguenauer O; O'Reilly M; Ross SR; Fan H; Rosenberg N; Somia N; King N; Friedmann T; Dunbar C; Aiuti A; Naldini L; Baum C; von Kalle C; Kiem H-P; Montini E; Bushman F; Sorrentino BP; Carrondo M; Malech H; Gahrton G; Shapiro R; Wolff L; Rosenthal E; Jambou R; Zaia J; Kohn DB
Meeting abstract: BLOOD. 2011;118(21):877
Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT
Morris C; Iacobelli S; Gahrton G; Garderet L; Drake M; van Biezen A; Mohty M; Blaise D; Poire X; Kersten MJ; Milpied N-J; Lenhoff S; Russell NH; Finke J; de Witte TM
Review: JOURNAL OF INTERNAL MEDICINE. 2011;269(2):137-147
Clinical impact of chromosomal aberrations in multiple myeloma
Nahi H; Sutlu T; Jansson M; Alici E; Gahrton G
Conference publication: BLOOD. 2011;118(21):1434
Risk Factors of Thromboembolic Events in Multiple Myeloma Treated with IMiDs-Based Therapy While on LMWH Prophylaxis
Leleu X; Iacobelli S; Barrois A; Pelle B; Clark L; Boyle E; Moreau P; Dib M; Caillot D; Niederwieser D; Masszi T; Fontan J; Doyen C; Hajek R; Onida F; Ludwig H; de Witte TM; Gahrton G; Morris CTCM; Garderet L
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S259
Efficacy and outcome of allogeneic transplantation in rare myeloma
Morris C; Iacobelli S; Garderet L; van Biezen A; Drake M; Gahrton G
Review: CURRENT GENE THERAPY. 2010;10(6):414-422
Relevance of an Academic GMP Pan-European Vector Infra-Structure (PEVI)
Cohen-Haguenauer O; Creff N; Cruz P; Tunc C; Aiuti A; Baum C; Bosch F; Blomberg P; Cichutek K; Collins M; Danos O; Dehaut F; Federspiel M; Galun E; Garritsen H; Hauser H; Hildebrandt M; Klatzmann D; Merten OW; Montini E; O'Brien T; Panet A; Rasooly L; Scherman D; Schmidt M; Schweizer M; Tiberghien P; Vandendriessche T; Ziehr H; Yla-Herttuala S; von Kalle C; Gahrton G; Carrondo M
Review: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(29):4521-4530
International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma
Lokhorst H; Einsele H; Vesole D; Bruno B; Miguel JS; Perez-Simon JA; Kroger N; Moreau P; Gahrton G; Gasparetto C; Giralt S; Bensinger W
Review: LEUKEMIA. 2010;24(10):1700-1712
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Terpos E; Dimopoulos MA; Sezer O; Roodman D; Abildgaard N; Vescio R; Tosi P; Garcia-Sanz R; Davies F; Chanan-Khan A; Palumbo A; Sonneveld P; Drake MT; Harousseau J-L; Anderson KC; Durie BGM; International Myeloma Working Group
Review: EUROPEAN JOURNAL OF HAEMATOLOGY. 2010;85(4):279-289
Progress in allogeneic transplantation for multiple myeloma
Gahrton G
Review: LEUKEMIA. 2010;24(6):1121-1127
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
Kyle RA; Durie BGM; Rajkumar SV; Landgren O; Blade J; Merlini G; Kröger N; Einsele H; Vesole DH; Dimopoulos M; San Miguel J; Avet-Loiseau H; Hajek R; Chen WM; Anderson KC; Ludwig H; Sonneveld P; Pavlovsky S; Palumbo A; Richardson PG; Barlogie B; Greipp P; Vescio R; Turesson I; Westin J; Boccadoro M; International Myeloma Working Group
Conference publication: HUMAN GENE THERAPY. 2010;21(10):1416
Expansion of NK cells for cancer immunotherapy: from process optimization to clinical evaluation
Sutlu T; Gahrton G; Alici E
Conference publication: BLOOD. 2010;116(21):1443-1444
A Comparison of Two Different Reduced Intensity Conditioning (RIC) Allograft Strategies In Patients with Multiple Myeloma, An EBMT Analysis
Sahebi F; Garderet L; Iacobelli S; van Biezen A; Gahrton G; Kroeger N; de Witte T; Morris C
Conference publication: BLOOD. 2010;116(21):1254
Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation.
Garderet L; Iacobelli S; Moreau P; Dib M; Caillot D; Niederwieser DW; Masszi T; Fontan J; Michallet M; Gratwohl A; Milone G; Doyen C; Pegourie B; Hajek R; Casassus P; Kolb B; Chaleteix C; Hertenstein B; Onida F; Ludwig H; Vekemans MC; Ketterer N; Daguenel A; Gorin NC; Harousseau JL; de Witte T; Morris C; Gahrton G
Meeting abstract: BLOOD. 2009;114(22):27
Tandem Autologous(ASCT)/Allogeneic Reduced Intensity Conditioning Transplantation (RIC) with Identical Sibling Donor Versus ASCT in Previously Untreated Multiple Myeloma (MM): Long Term Follow up of a Prospective Controlled Trial by the EBMT
Gahrton G; Bjorkstrand B; Iacobelli S; Hegenbart U; Gruber A; Greinix H; Volin L; Narni F; Musto P; Beksac M; Bosi A; Milone G; Corradini P; Goldschmidt H; de Witte T; Morris C; Niederwieser D
Review: LEUKEMIA. 2009;23(10):1716-1730
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation.
Palumbo A; Sezer O; Kyle R; Miguel JS; Orlowski RZ; Moreau P; Niesvizky R; Morgan G; Comenzo R; Sonneveld P; Kumar S; Hajek R; Giralt S; Bringhen S; Anderson KC; Richardson PG; Cavo M; Davies F; Bladé J; Einsele H; Dimopoulos MA; Spencer A; Dispenzieri A; Reiman T; Shimizu K; Lee JH; Attal M; Boccadoro M; Mateos M; Chen W; Ludwig H; Joshua D; Chim J; Hungria V; Turesson I; Durie BGM; Lonial S; IMWG
Review: LEUKEMIA. 2009;23(9):1545-1556
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BGM; IMWG
Other: JOURNAL OF INTERNAL MEDICINE. 2009;265(5):618-619
Professor Lars Erik Bottiger, in memoriam (1924-2009)
de Faire U; Fagrell B; Holm G; Gahrton G; Hallberg L
Review: LEUKEMIA. 2009;23(2):215-224
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BGM; International Myeloma Working Group
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2009;144(2):266-268
The prognostic significance of 8p21 deletion in multiple myeloma
Sutlu T; Alici E; Jansson M; Wallblom A; Dilber MS; Gahrton G; Nahi H
Conference publication: BLOOD. 2009;114(22):911
Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
Kroger N; Shimoni A; Schilling G; Schwerdtfeger R; Bornhaeuser M; Nagler A; Zander AR; Heinzelmann M; Brand R; Gahrton G; Morris C; Niederwieser D; de Witte TM
Conference publication: CLINICAL LYMPHOMA AND MYELOMA. 2009;9:S27-S28
Efficacy and Outcome of Autologous Transplantation in Rare Myelomas
Morris T; Drake MB; Apperley JF; Iaccobelli S; Niederwieser D; van Biezen A; Bjorkstrand B; Gahrton G
Editorial comment: HAEMATOLOGICA. 2008;93(9):1295-1300
Allogeneic transplantation in multiple myeloma
Gahrton G; Bjorkstrand B
Editorial comment: LEUKEMIA. 2008;22(8):1479-1484
The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement.
Hussein MA; Vrionis FD; Allison R; Berenson J; Berven S; Erdem E; Giralt S; Jagannath S; Kyle RA; LeGrand S; Pflugmacher R; Raje N; Rajkumar SV; Randall RL; Roodman D; Siegel D; Vescio R; Zonder J; Durie BGM; International Myeloma Working Group
Conference publication: HUMAN GENE THERAPY. 2008;19(10):1183
Ex vivo expanded autologous natural killer cells as a novel therapeutic approach in multiple myeloma
Alici E; Sutlu T; Bjokstrand B; Gilljam M; Stellan B; Nahi H; Quezada HC; Gahrton G; Ljunggren H-G; Dilber MS
Conference publication: HUMAN GENE THERAPY. 2008;19(10):1141
Optimal ouaselect and thymidine kinase functionality in T cells is defined by the transgene cassette
Treschow A; Schambach A; Felldin U; Alici E; Gahrton G; Fehse B; Baum C; Dilber MS
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S38
Primary plasma cell leukaemia treated with autologous stem cell transplantation
Drake MB; Iacobelli S; van Biezen A; Apperley JF; Niederwieser D; Bjorkstrand B; Gahrton G; Morris C
Meeting abstract: BLOOD REVIEWS. 2007;21:S10-S12
Stem cell transplantation in multiple myeloma
Gahrton G
Corrigendum: LEUKEMIA. 2007;21(5):1134
International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006)
Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Conference publication: HUMAN GENE THERAPY. 2007;18(10):992-993
Natural killer cells kill syngeneic myeloma cells in C57Bl/KaLwRij upon adoptive transfer
Alici E; Sutlu T; Gahrton G; Dilber S
Corrigendum: LEUKEMIA. 2006;20(12):2220
International uniform response criteria for multiple myeloma (vol 20, pg 1467, 2006)
Durie BGM; Harousseau J-L; Miguel JS; Blade J; Barlogie B; Anderson K; Gertz M; Dimopoulos M; Westin J; Sonneveld P; Ludwig H; Gahrton G; Beksac M; Crowley J; Belch A; Boccadaro M; Turesson I; Joshua D; Vesole D; Kyle R; Alexanian R; Tricot G; Attal M; Merlini G; Powles R; Richardson P; Shimizu K; Tosi P; Morgan G; Rajkumar SV
Published conference paper: HEMATOLOGY. 2005;10:127-128
Role of stem cell transplantation in myeloma
Gahrton G; Iacobelli S; Björkstrand B; Bourhis J; Corradini P; Crawley C; Morris C; Niederwieser D
Meeting abstract: BLOOD. 2004;104(11):264A
Long term follow-up shows no clinical benefit for CD34⁺ selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma:: An EBMT phase III randomized study.
Bourhis JH; Bouko Y; Koscielny S; Greinix H; Derigs G; Salles G; Feremans W; Bakkus M; Apperley J; Samson D; Bjorkstrand B; Niederwieser D; Gahrton G; Pico JL; Goldschmidt H
Meeting abstract: BLOOD. 2004;104(11):430A
Disruption of the HEXB/ENC-1 antisense gene and identification of elevated ENC-1 expression in patients with Hairy Cell Leukemia
Lerner M; Hammarsund M; Sangfelt O; Zhu CY; Merup M; Jansson M; Gahrton G; Kluin-Nelemans H; Einhorn S; Grander D; Corcoran M
Editorial comment: LANCET. 2004;364(9446):1648-1649
New therapeutic targets in multiple myeloma
Gahrton G
Book chapter: MULTIPLE MYELOMA AND RELATED DISORDERS. 2004;p. 234-254
Chemotherapy, steroids, and interferon
Gahrton G; Ljungman P
Book chapter: MULTIPLE MYELOMA AND RELATED DISORDERS. 2004;p. 274-288
Allogeneic transplantation and treatment with donor lymphocytes
Gahrton G; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S148
Conventional HLA-identical sibling bone marrow transplantation is able to cure chronic lymphocytic leukaemia. A study from the EBMT and IBMT Registries
Michallet M; Michallet AS; Le Q; Bandini G; Rowlings PA; Deeg HJ; Gahrton G; Montserrat E; Nicolini F; Rozman C; Gratwohl A; Niederweiser D; Bredeson C; Horowitz M
Book chapter: BIOLOGY AND MANAGEMENT OF MULTIPLE MYELOMA: CURRENT CLINICAL ONCOLOGY. 2004;p. 183-203
Allogeneic Transplantation in Multiple Myeloma
Gahrton G; Anderson KC; Bensinger W
Book chapter: THOMAS' HEMATOPOIETIC CELL TRANSPLANTATION. 2003;p. 1096-1104
Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma
Maloney DG; Gahrton G
Conference publication: BLOOD. 2003;102(11):988A
CD34⁺ selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years:: An EBMT phase III randomized study
Bourhis JH; Bouko Y; Koscielny S; Greinix H; Derigs G; Salles G; Feremans W; Bakkus M; Apperley J; Samson D; Gahrton G; Pico JL; Goldschmidt H
Published conference paper: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2002;76 Suppl 1:384-385
Goals and activities of the WMDA. World Marrow Donor Association.
Gahrton G
Review: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):359-367
Suicide gene therapy: possible applications in haematopoietic disorders
Dilber MS; Gahrton G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2001;249(4):327-328
Haematopoietic cell gene therapy - Introduction
Gahrton G
Review: JOURNAL OF INTERNAL MEDICINE. 2000;248(3):185-201
Progress in haematopoietic stem cell transplantation for multiple myeloma
Gahrton G; Björkstrand B
Conference publication: BLOOD. 2000;96(11):798A
If double autologous PBSC transplants have a role in myeloma when are they best performed? An EBMT Registry study.
Morris TCM; Svensson H; Bjorkstrand B; Gahrton G
Conference publication: BLOOD. 2000;96(11):703A
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia and its homologous region on mouse chromosome 14.
Kapanadze B; Makeevaa N; Corcoran MM; Jareborg N; Hammarsund M; Baranova A; Zabarovsky E; Vorontcova O; Merup M; Jansson O; Gahrton G; Oscier DG; Einhorn S; Grander D; Sangfelt O
Conference publication: BLOOD. 2000;96(11):702A-703A
Characterisation of a candidate tumor suppressor gene LEU2B located at 13q14.3 in chronic lymphocytic leukemia.
Corcoran MM; Sangfelt O; Kapanadze B; Makeevaa N; Ibbotson RE; Baranova A; Zabarovsky E; Merup M; Jansson O; Gahrton G; Einhorn S; Grander D; Oscier DG
Review: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 1999;30(2):173-180
High-dose treatment of multiple myeloma
Gahrton G; Björkstrand B
Editorial comment: LANCET. 1999;353(9147):85-86
Treatment of multiple myeloma
Gahrton G
Conference publication: BONE MARROW TRANSPLANTATION. 1999;23:S133
Autologous stem cell transplantation (ASCT) in multiple myeloma (MM) -: The 1999 EBMT registry update.
Björkstrand B; Svensson H; Goldschmidt H; Ljungman P; Apperley J; Remes K; Marcus R; Barbui T; Sureda A; Lenhoff S; de Laurenzi A; Bladé J; Ferrant A; Goldstone AH; Gahrton G
Conference publication: BLOOD. 1999;94(10):190B
Identification of tumor suppressor gene candidates associated with hairy cell leukemia.
Wu XS; Ivanova G; Merup M; Jansson M; Stellan B; Grander D; Zabarovsky E; Gahrton G; Einhorn S
Conference publication: BLOOD. 1999;94(10):188B
6q deletions in pediatric acute lymphoblastic leukemia.
Calero T; Heyman M; Merup M; Grandér D; Rasool O; Söderhäll S; Gahrton G; Einhorn S
Conference publication: BLOOD. 1999;94(10):714A
5489 autotransplants in multiple myeloma -: A registry study from the European group for blood and marrow transplantation (EBMT).
Bjorkstrand BT; Svensson H; Goldschmidt H; Ljungman PT; Apperley J; Remes K; Marcus R; Barbui T; Alegre A; Majolino I; Carlson K; Boogaerts M; Coser P; Iriondo A; Sureda A; Lenhoff S; de Laurenzi A; Bladé J; Ferrant A; Goldstone AH; Gahrton G
Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1998;451:493-497
Gene marking and gene therapy in multiple myeloma
Gahrton G; Björkstrand B; Dilber MS; Sundman-Engberg B; Ljungman P; Smith CIE
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S208
Alpha-interferon treatment after autologous stem cell transplantation in multiple myeloma -: A retrospective case-matched analysis.
Björkstrand B; Svensson H; Ljungman P; Apperley J; Remes K; Alegre A; Marcus R; Carlson K; Coser P; Sureda A; Barbui T; Goldstone AH; Bladé J; Volin L; Boogaerts M; Lenhoff S; Majolino I; Samson D; de Laurenzi A; San Miguel JF; Gahrton G
Conference publication: BONE MARROW TRANSPLANTATION. 1998;21:S208
Autologous stem cell transplantation in multiple myeloma -: The 1998 EBMT registry update
Bjorkstrand B; Svensson H; Ljungman P; Apperley J; Goldschmidt H; Remes K; Alegre A; Marcus R; Carlson K; Coser P; Sureda A; Barbui T; Goldstone AH; Bladé J; Volin L; Boogaerts M; Lenhoff S; Majolino I; Samson D; de Laurenzi A; San Miguel JF; Gahrton G
Editorial comment: ANNALS OF ONCOLOGY. 1997;8(3):219-221
Bone marrow and peripheral blood stem cell transplantation in multiple myeloma
Gahrton G
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 1997;242:U2
International Society of Haematology (European and African Division) XIV Meeting - 30 August 4 September 1997 Stockholm, Sweden - Education Programme - President's message
Gahrton G
Conference publication: BLOOD. 1997;90(10):1862
2522 autotransplants in multiple myeloma - A registry study from the European group for blood and marrow transplantation (EBMT).
Bjorkstrand B; Svensson K; Ljungman P; Apperley J; Goldschmidt H; Remes K; Alegre A; Marcus R; Carlson K; Coser P; Sureda A; Barbui T; Goldstone AH; Blade J; Volin L; Boogaerts M; Lenhoff S; Majolino I; Samson D; deLaurenzi A; Caballero D; Gahrton G
Conference publication: CANCER GENE THERAPY. 1997;4(5):331
Autologous stem cell transplantation with gene marked cells in multiple myeloma
Bjorkstrand B; Smith CIE; Sundberg M; SundmanEngberg B; Dilber MS; Ljungman P; Gahrton G
Conference publication: BLOOD. 1997;90(10):1845
Cloning of two candidate tumor suppressor genes within a 10 kB region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.
Einhorn S; Liu Y; Corcoran M; Rasool O; Ivanova G; Ibbotson R; Grander D; Iyengar A; Baranova A; Kashuba V; Mullenbach R; Merup M; Wu X; Gardiner A; Poltaraus A; Hultstrom AL; Juliusson G; Chapman R; Tiller M; Gahrton G; Yankovsky N; Zabarovsky E; Oscier D
Conference publication: BLOOD. 1997;90(10):3602
Deletion of 6q in acute lymphoblastic leukemia and non-Hodgkin's lymphomas.
Merup M; Moreno TC; Heyman M; Grander D; Gahrton G; Einhorn S
Conference publication: EXPERIMENTAL HEMATOLOGY. 1997;25(8):496
6q deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas.
Merup M; Moreno TC; Heyman M; Grander D; Gahrton G; Einhorn S
Conference publication: BLOOD. 1997;90(10):3705
Detection of trisomy 12 in subpopulations of clonal B cells in patients with B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization in combination with immunophenotyping (FICTION).
Kimby E; Stellan B; Gahrton G
Conference publication: BLOOD. 1997;90(10):4590
Reverse flow-through transduction: A new method for gene delivery.
Branden L; Smith CIE; Gahrton G
Letter: LANCET. 1996;348(9023):346
Graft-versus-myeloma effect
Aschan J; Lonnqvist B; Ringden O; Kumlien G; Gahrton G
Published conference paper: BONE MARROW TRANSPLANTATION. 1996;17:S63-S64
Intensive treatment in order to minimize the Ph-positive clone in CML
Simonsson B; Oberg G; Bjoreman M; Bjorkholm M; Carneskog J; Gahrton G; Hast R; Karl H; LanngNielsen J; Lofvenberg E; Malm C; Turesson I; Uden AM; Vilen L; WeisBjerrum O
Review: BONE MARROW TRANSPLANTATION. 1996;17(1):13-18
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Conference publication: EXPERIMENTAL HEMATOLOGY. 1996;24(9):657
Autologous stem cell transplantation is associated with better survival than allogeneic BMT in multiple myeloma - Results of a retrospective case-matched study in 378 patients.
Bjorkstrand B; Ljungman P; Svensson H; Hermans I; Alegre A; Apperley I; Blade I; Carlson K; Cavo M; Ferrant A; Goldstone AH; deLaurenzi A; Majolino I; Marcus R; Prentice HG; Remes K; Samson D; Sureda A; Verdonck LF; Volin L; Gahrton G
Conference publication: BRITISH JOURNAL OF HAEMATOLOGY. 1996;93:520
Bone marrow transplantation for AML; An update of the EBMT registration study
Ljungman P; deWitte T; Verdonck L; Freycon F; Gahrton G; Gravett PJ; McCann S; Morgenstern HG; Nikoskelainen J; Powles R; Proctor SJ; Volin L; Zwaan F; Gratwohl A
Conference publication: BLOOD. 1996;88(10):1419
Characterisation of the minimal area of homozygous 13q14.3 deletion in B-CLL and isolation of candidate tumour suppressor genes.
Corcoran M; Liu Y; Mullenbach R; Ibbotson R; Rasool O; Iyengar A; Grander D; Chapman R; Yankovsky N; Wu X; Merup M; Juliusson G; Gahrton G; Brodyansky V; Buys C; Zabarovsky E; Oscier D; Einhorn S
Conference publication: BLOOD. 1996;88(10):252
Characterization of the hairy cell leukemia-associated breakpoint at 5q13.3 in a patient with a constitutional inversion.
Wu X; Merup M; Juliusson G; Jansson M; Stellan B; Grander D; Zabarovsky E; Liu Y; Spaskoukotskaja T; Gahrton G; Einhorn S
Conference publication: BRITISH JOURNAL OF HAEMATOLOGY. 1996;93:448
Amplification of chromosome 12q13.1-14.3 in a case of chronic lymphocytic leukemia
Merup M; Einhorn S; Wu XS; Gahrton G; Juliusson G
Conference publication: CYTOGENETIC AND GENOME RESEARCH. 1996;75(2-3):108
Chromosome 13q14 deletions in lymphoid malignancies
Liu Y; Wu X; Hermason M; Zabarovsky E; Grander D; Gahrton G; Juliusson G; Rassol M; Buys C; Yankovsky N; Einhorn S
Conference publication: EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 21ST ESMO CONGRESS, EDUCATIONAL BOOK. 1996;:165-170
High-dose chemotherapy in multiple myeloma
Gahrton G; Bjorkstrand B
Review: WIENER MEDIZINISCHE WOCHENSCHRIFT. 1995;145(2-3):52-54
Autologous stem-cell transplantation in multiple myeloma.
Gahrton G
Conference publication: CYTOGENETIC AND GENOME RESEARCH. 1995;70(1-2):19
EVIDENCE FOR A NEW TUMOR-SUPPRESSOR GENE AT 13Q14 IN CHRONIC LYMPHOCYTIC-LEUKEMIA
LIU Y; GAHRTON G; GRANDER D; JULIUSSON G; SODERHALL S; EINHORN S
Conference publication: BLOOD. 1994;84(10):A535
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) IN MULTIPLE-MYELOMA - A STUDY OF THE EUROPEAN BMT REGISTRY
BJORKSTRAND B; LJUNGMAN P; BRANDT L; BRUNET S; CARLSON K; CAVO M; FASSAS A; FERRANT A; GOLDSTONE AH; DELAURENZI A; PRENTICE HG; REMES K; SAMSON D; VERDONCK LF; GAHRTON G
Conference publication: BLOOD. 1994;84(10):A208
ERADICATION OF MINIMAL RESIDUAL DISEASE, ANALYZED BY PCR, AFTER DOUBLE HIGH-DOSE CHEMORADIOTHERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA
BJORKSTRAND B; LJUNGMAN P; BIRD JM; SAMSON D; GAHRTON G
Conference publication: BLOOD. 1994;84(10):A657
ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY
OSTERBORG A; BJORKHOLM M; BJOREMAN M; BRENNING G; CARLSON K; CELSING F; GAHRTON G; GRIMFORS G; GYLLENHAMMAR H; HAST R; JOHANSSON B; JULIUSSON G; JARNMARK M; KIMBY E; LERNER R; LINDEMALM C; LINDER O; OHRLING M; PAUL C; SIMONSSON B; SKARBERG KF; SMEDMYR B; STRANDER H; SVEDMYR E; TIDEFELT U; UDEN AM; WERNER B; OSBY E; MELLSTEDT H
Conference publication: BONE MARROW TRANSPLANTATION. 1994;14:S55-S56
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML)
SIMONSSON B; OBERG G; KILLANDER A; BJOREMAN M; BJORKHOLM M; GAHRTON G; STENKE L; TURESSON I; UDEN AM; MALM C; VILEN L; WAHLIN A; LOFVENBERG E; CARNESKOG J; WESTIN J
Conference publication: BLOOD. 1994;84(10):A443
BCL-2 REARRANGEMENT INVOLVING VARIANT AND MAJOR BREAKPOINT REGIONS IN LOW-GRADE AND HIGH-GRADE NON-HODGKIN-LYMPHOMA
MERUP M; JULIUSSON G; SMITH CIE; GAHRTON G
Conference publication: STEM CELLS. 1993;11:73-76
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA
SIMONSSON B; OBERG G; KILLANDER A; BJOREMAN M; BJORKHOLM M; GAHRTON G; HAST R; TURESSON I; UDEN AM; MALM C; VILEN L; WAHLIN A; LOFVENBERG E; CARNESKOG J; WESTIN J
Conference publication: BLOOD. 1993;82(10):A392
CONSTITUTIONAL AND ACQUIRED ABNORMALITIES OF CHROMOSOME-5 BAND-Q13 IN PATIENTS WITH HAIRY-CELL LEUKEMIA (HCL)
JULIUSSON G; HAGLUND U; GAHRTON G
Conference publication: LEUKEMIA. 1992;6:89-91
DNA AS A CARRIER FOR ANTHRACYCLINES IN THE TREATMENT OF ACUTE MYELOCYTIC-LEUKEMIA (AML)
GAHRTON G; TIDEFELT U; PAUL C; BJORKHOLM M; GRIMFORS G; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LILIEMARK J; LINDQUIST R; LOCKNER D; LONNQVIST B; MELLSTEDT H; MERK K; PALMBLAD J; PETERSON C; SIMONSSON B; STALFELT AM; SUNDSTROM C; UDEN AM; WADMAN B; OBERG G; OST A
Conference publication: EXPERIMENTAL HEMATOLOGY. 1992;20(6):781
A PREDICTIVE MODEL FOR THE CLINICAL-RESPONSE TO LOW-DOSE ARA-C - A STUDY OF 102 PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE-LEUKEMIA
HELLSTROMLINDBERG E; ROBERT KH; GAHRTON G; LINDBERG G; FORSBLOM AM; KOCK Y; OST A
Conference publication: EXPERIMENTAL HEMATOLOGY. 1991;19(6):576
HOST ERYTHROPOIESIS AT RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IS SEEN IN MYELOID-LEUKEMIA BUT NOT IN LYMPHOPROLIFERATIVE DISEASE
BJORKSTRAND B; SHANWELL A; LONNQVIST B; RINGDEN O; GAHRTON G
Conference publication: LEUKEMIA & LYMPHOMA. 1991;5:21-25
CYTOGENETIC FINDINGS AND SURVIVAL IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - 2ND IWCCLL COMPILATION OF DATA ON 662 PATIENTS
JULIUSSON G; GAHRTON G; OSCIER D; FITCHETT M; ROSS F; BRITOBABAPULLE V; CATOVSKY D; KNUUTILA S; ELONEN E; LECHLEITNER M; TANZER J; SCHOENWALD M; CASTOLDI GL; CUNEO A; NOWELL P; PETERSON L; KAY N
Book chapter: THE MANAGEMENT OF NON-HODGKIN’S LYMPHOMAS IN EUROPE: ESO INTERCITY REPORT. 1990;p. 51-58
Management of Non-Hodgkin’s Lymphomas in Adults in Scandinavia, the United Kingdom and the Netherlands: Conclusions of the Fourth Intercity Meeting, 1988
Juliusson G; Abrahamsen AF; Cavallin-Ståhl E; Goldstone AH; Lister A; Nissen NI; Robèrt K-H; Singer CRJ; Somers R; Öst Å; Gahrton G
Book chapter: THE MANAGEMENT OF NON-HODGKIN’S LYMPHOMAS IN EUROPE: ESO INTERCITY REPORT. 1990;p. 89-92
Conclusions
Monfardini S; Coiffier B; Estapé J; Gahrton G
Conference publication: ETHICS IN MEDICINE. 1990;:65-68
PRIORITIES FOR TREATMENT WITH HIGHLY SPECIALIZED TECHNOLOGY - BONE-MARROW TRANSPLANTATION
GAHRTON G
Conference publication: ETHICS IN MEDICINE. 1990;:53-54
PRIORITIES IN MEDICAL HEALTH-CARE - INTRODUCTION
GAHRTON G
Conference publication: BONE MARROW TRANSPLANTATION. 1989;4:95-97
CYTOGENETIC MONITORING IN CML PATIENTS TREATED WITH BMT
ROSTI G; ZACCARIA A; TESTONI N; CELSO B; BANDINI G; TASSINARI A; ALBERTAZZI L; MIGGIANO C; TURA S; SESSAREGO M; MARMONT AM; GUALANDI F; FRASSONI F; GALIMBERTI M; FILIPPETTI DBA; DIBARTOLOMEO P; DIGIROLAMO G; PALKA G; IZZI T; CAPUCCI A; HINTERBERGER W; POLLAK C; HAAS OA; MICHAUX JL; FERRANT A; MECUCCI C; VANDENBERGHE H; GAHRTON G; LINDQUIST R
Conference publication: EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPLEMENT. 1989;43:182-185
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA
GAHRTON G; TURA S; BELANGER C; CAVO M; CHAPVIS B; FERRANT A; FLESCH M; GORE M; GRATWOHL A; GRAVETT PJ; HARROUSEAU JL; LINDEBERG A; LJUNGMAN P; LOWENBERG B; LUCARELLI G; MICHALLET M; REIFFERS J; RINGDEN O; VANLINT MT; VERNANT JP; SALLERFORS B; SIMONSSON B; TOIVANEN A; TROUSSARD X; VERDONCK LF; VOLIN L; ZWAAN FE
Conference publication: EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPLEMENT. 1989;43:124-128
INDUCTION TREATMENT WITH ALPHA-INTERFERON IN MULTIPLE-MYELOMA - AN INTERIM-REPORT FROM MGCS
MELLSTEDT H; OSTERBORG A; BJORKHOLM M; BJOREMAN M; BRENNING G; GAHRTON G; GRIMFORS G; GYLLENHAMMAR H; HAST R; JOHANSSON B; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; MERK K; PAUL C; SIMONSSON B; SMEDMYR B; STALFELT AM; STRANDER H; SVEDMYR E; UDEN AM; WADMAN B; OSBY E
Book chapter: RECENT ADVANCES AND FUTURE DIRECTIONS IN BONE MARROW TRANSPLANTATION: EXPERIMENTAL HEMATOLOGY TODAY. 1988;p. 161-164
Predictive Factors for Chronic Graft-versus-Host Disease and Leukemic Relapse After Allogeneic Bone Marrow Transplantation
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Ruutu T; Rajantie J; Siimes MA; Nikoskelainen J; Toivanen A; Andersen HK; Keiding N; Gahrton G
Book chapter: TUMOR CELL DIFFERENTIATION: EXPERIMENTAL BIOLOGY AND MEDICINE. 1987;p. 205-212
Therapeutic Effects of Low-Dose Cytosine Arabinoside, α-Interferon, 1,25-Dihydroxyvitamin D3 and Retinoic Acid in Myelodysplastic Syndromes and Acute Leukemia
Hellström E; Robèrt K-H; Gahrton G; Mellstedt H; Lindemalm C; Einhorn S; Björkholm M; Grimfors G; Udén A-M; Samuelsson J; Öst Å; Killander A; Nilsson B; Winqvist I; Olsson I
Conference publication: JOURNAL OF INTERFERON RESEARCH. 1987;7(6):836
INFLUENCE OF INTERFERON-ALPHA ON THE EXPRESSION OF PROTOONCOGENES IN PRIMARY CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
EINHORN S; SHOWE L; OSTLUND L; JULIUSSON G; ROBERT KH; GAHRTON G; CROCE C
Conference publication: ACTA PHARMACOLOGICA ET TOXICOLOGICA. 1986;59:127
COMPARATIVE-EVALUATION OF BONE-MARROW TRANSPLANTATION AND CONVENTIONAL CHEMOTHERAPY IN LEUKEMIA
GAHRTON G; RINGDEN O; LONNQVIST B; LJUNGMAN P
Conference publication: PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. 1986;27:170
LONG RETENTION OF ARACTP IN LEUKEMIC-CELLS AFTER SC INJECTION OF ARAC IN PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA
LILIEMARK J; GAHRTON G; PAUL C; PETERSON C
Book chapter: 11TH ANNUAL MEETING OF THE EBMT: EXPERIMENTAL HEMATOLOGY TODAY. 1985;p. 72
Frequency of Reactivation of Varicella-Zoster Virus (VZV) Infection with and without Symptoms After Bone Marrow Transplantation
Lönnqvist B; Ljungman P; Bolme P; Gahrton G; Ringdén O; Wahren B
Book chapter: 11TH ANNUAL MEETING OF THE EBMT: EXPERIMENTAL HEMATOLOGY TODAY. 1985;p. 133
Lymphocyte Reactivity After Cytomegalovirus Infection May Predict Development of Chronic Graft Versus Host Disease
Ljungman P; Gahrton G; Lönnqvist B; Ringdén O; Wahren B
Conference publication: CLINICAL GENETICS. 1985;27(3):346
MARKER CHROMOSOMES, INV(14) AND +8Q, IN CHRONIC LYMPHOCYTIC T-CELL LEUKEMIA
ZECH L; HAMMARSTROM L; SMITH CIE; GAHRTON G; ROBERT KH; JULIUSSON G; MELLSTEDT H
Book chapter: MALIGNANT LYMPHOMAS AND HODGKIN’S DISEASE: EXPERIMENTAL AND THERAPEUTIC ADVANCES: DEVELOPMENTS IN ONCOLOGY. 1985;p. 81-87
Chromosomal aberrations in leukemic low-grade malignant B-cell lymphoproliferative neoplasias
Gahrton G; Juliusson G; Robert KH; Friberg K; Zech L
Conference publication: EXPERIMENTAL HEMATOLOGY. 1982;10:11
SELECTIVE DECONTAMINATION OF THE ORAL AND GASTROINTESTINAL MICROFLORA IN PATIENTS TREATED WITH BMT
HEIMDAHL A; LONNQVIST B; GAHRTON G; GROTH CG; LUNDGREN G; NORD CE; RINGDEN O
Book chapter: ANTHRACYCLINE ANTIBIOTICS IN CANCER THERAPY: DEVELOPMENTS IN ONCOLOGY. 1982;p. 132-146
Transport and Storage of Anthracyclines in Experimental Systems and Human Leukemia
Peterson C; Paul C; Gahrton G; Vitols S; Rudling M
Book chapter: CONTROLLED RELEASE OF PESTICIDES AND PHARMACEUTICALS. 1981;p. 49-65
Anthracycline-DNA Complexes as Slow-Release Preparations in the Treatment of Acute Leukemia
Peterson C; Paul C; Gahrton G
Book chapter: THIRD INTERNATIONAL CONGRESS OF HISTOCHEMISTRY AND CYTOCHEMISTRY. 1968;p. 1-317
Third International Congress of Histochemistry and Cytochemistry
Abe M; Akamatsu M; Matsumoto T; Ohuchi N; Masuya T; Abe T; Nakashio K; Kazama M; Matsuda M; Adams CWM; Virág S; Morgan RS; Orton CC; Adams JR; Wilcox TA; Akert K; Alberti R; Allen RC; Moore DJ; Tyndall RL; Anderson PJ; Song SK; Angelakos ET; King MP; Appleton TC; Arstila AU; Trump BF; Lauria A; Bahr GF; Wied GL; Bartels PH; Bajusz E; Balogh K; Barer R; Barka T; Barnard EA; Komender J; Wieckowski J; Barrnett RJ; Barron KD; Koeppen AH; Bernsohn J; Bélanger LF; Beltrami CA; Björklund A; Ehinger B; Falck B; Boadle MC; Bloom FE; Bona C; Bradshaw M; Monus L; Stroman S; Budd GC; Salpeter MM; Bukhonova AI; Burnasheva SA; Jurzina GA; Burt AM; Chang JP; Schatzki PF; Saito T; Chavin W; Chyle M; Korych B; Lojda Z; Patocka F; Cohn ZA; Conning DM; Coutinho HB; Rocha JT; Jales BF; Cunningham L; Heitsch R; Daneholt B; Edström J-E; Danilova LV; Rokhlenko KD; Dauwalder M; Whaley WG; Kephart JE; Deitch AD; Sawicki SG; Godman GC; Della Corte F; Desmet VJ; Bullens A-M; De Groote J; Heirwegh KPM; Diculescu I; Onicescu D; Szegly G; Doane WW; Donskikh NV; Novikov VD; Subbotin MY; Tsirelnikov NI; Doolin PF; Birge WJ; Droz B; Bergeron M; Drukker J; Duarte-Escalante O; Dubowitz V; Dupraw EJ; Eckner FAO; Blackstone EH; Moulder PV; Ehrlich MP; Ellis S; McDonald JK; Callahan PX; Enesco HE; Engel WK; Epifanova OI; Lomakina LY; Terskikh VV; Ericsson JLE; Jakobsson S; Eristawi KD; Sharashidze LK; Sturua NS; Fabris G; Mariuzzi G; Nenci I; Fahimi HD; Karnovsky MJ; Fand SB; Farquhar MG; Felgenhauer K; Glenner GG; Stammler A; Filkuka J; Svejda J; Áubrechtova V; Filotto U; Fischbein JW; Rutenburg AM; Fisher DB; Forni A; Nencioni T; Ballare’ G; Fotin L; Popescu M; Frankfurt OS; Friend DS; Fuchs BB; Arutyunov VD; Shnaper AL; Gabunia UA; Shiukashvili NN; Gahan PB; Anker P; Stroun M; McLean J; Galjaard H; Bootsma D; Ganina KP; Garcia AM; Garrett JR; Gepts W; Gregoire F; Ooms H; Gerzeli G; Giacobini E; Hovmark S; Gilkerson SW; Glick D; Godlewski HG; Huszczuk A; Penar B; Goldfischer S; Sternlieb I; Goldstone A; Szabo E; Koenig H; Gornak KA; Goslar HG; Grigoriadis P; Jaeger KH; Gössner W; Benoit H; Gracheva ND; Grillo TAI; Gropp A; Gross UM; Gueft B; Guha S; Fouquet JP; Håkanson R; Owman C; Sporrong B; Hale AJ; Marshall DJ; Switsur VR; Hanker JS; Zenker N; Morizono Y; Deb C; Seligman AM; Hardonk MJ; Elema JD; Koudstaal J; Hoedemaeker PJ; Hayashi M; Heller A; Hernández F; Martinez De Morentin J; Herrmann H-J; Hershey FB; Hess HH; Pope A; Bass NH; Hewitt JM; Guigon M; Bolubasz J; Himes MH; Burdick C; Hirai K-I; Takamatsu H; Hirose S; Hirsch HE; Hodges DR; Costoff A; McShan WH; Holtzman E; Holubar K; Tappeiner J; Wolff K; Hopsu-Havu VK; Hosannah Y; Blackwood CE; Mandl I; Hoskins GC; Hugon JS; Borgers M; Hurwitz LS; Rubinstein LJ; Ibrahim MZM; Imura S-I; Takeda M; Jacobsen NO; Jørgensen PL; Jarrett A; Joandrea-Casian C; Prundeanu C; Johnson AB; Johnson WC; Alkek DS; Jongkind JF; Swaab DF; Jos J; Junqueira LC; Toledo AMS; Kaiser HE; Kakari S; Kalina M; Bubis JJ; Kamentsky LA; Kasten FH; Kiefer GG; Sandritter W; Killander D; Rigler R; Kishino Y; Kobayashi H; Urano A; Yokoyama K; Koelle GB; Hughes C; Korhonen LK; Kramer MF; Poort C; Kreutzberg GW; Künzel E; Tanyolac A; Labella FS; Langley OK; Lanza GB; Lappano-Colletta ER; Leblond CP; Merzel J; Cheng H; Nadler NJ; Herscovics AA; Lederer B; Mittermayer C; Lee SH; Torack RM; Lehrer GM; Bornstein MB; Katzman R; Leites FL; Tendetnik JJ; Ruchadse ES; Rjadneva OE; Leppi TJ; Kinnison PA; Gaffney SP; Lev R; Gerard A; De Graef J; Jerzy Glass GB; Lhotka JF; Anderson JW; Liber AF; Lillie RD; Pizzolato P; Lindner J; Grasedyck K; Johannes G; Freytag G; Lipchina LP; Aksyutina MS; Yablonovskaya LY; Lipetz J; Liu JC; Roizin L; Lodin Z; Kage M; Hartman J; Srajer J; Fric P; Long ME; Sommers SC; McGarry EE; Nayak R; Birch E; Beck JC; McMillan PJ; Adeoye CS; Macovschi O; Maeda R; Ihara N; Kanazawa K; Maeir DM; Wagner L; Maggi V; Franks LM; Livingston DC; Coombs MM; Wilson PD; Carbonell AW; Malyuk VI; Romanini M; Gabriella M; Fraschini A; Porcelli F; Manocha SL; Shantha TR; Bourne GH; Marques D; Bastos AL; Baptista AM; Vigario JD; Nunes JM; Terrinha AM; Silva JAF; Masurovsky EB; Benitez HH; Kim S-U; Murray MR; Matschinsky FM; Rutherford CL; Guerra L; Matturri L; Curri S; Melnick PJ; Mendelsohn ML; Conway TJ; Perry B; Prewitt JMS; Mercado TI; Miksche JP; Misch DW; Misch MS; Mitchell JP; Mizuhira V; Uchida K; Amakawa T; Shindo H; Totsu J; Suesada I; Mizutani A; Monis B; Candiotti A; Mori G; Ingrami A; Morikawa S; Yamamura M; Harada T; Hamashima Y; Mullaney PF; Dean PN; Van Dilla MA; Müller G; Müller O; Nakane PK; Neurath PW; Curtis ZB; Selles W; Vetter HG; Norgren PE; Novikoff AB; O’Brien R; Ohringer P; Spitaleri V; Olszewska MJ; Gabara B; Konopska L; Parfanovich MI; Sokolov NN; Berezina ON; Fadeeva LL; Pauly JE; Scheving LE; Pearse AGE; Pearson B; Bennett W; Esterly JR; Standen AC; Pelc SR; Viola-Magni MP; Penttilä A; Perez VJ; Moore BW; Peters T; Danzi JT; Ashley CA; Petrova AS; Probatova NA; Philippens K; Pilgrim C; Pollock BM; Presnov MA; Preston K; Preto Parvis V; Cisotti F; Prewitt JMS; Mayall BH; Mendelsohn ML; Pryse-Davis J; Sandler M; Quay WB; Raikhlin NT; Rasch EM; Riecken EO; Goebell H; Bode C; Rigatuso JL; Ringertz NR; Bolund L; Ritter C; Thorell B; Rizzotti M; Aureli G; Balduini C; Castellani AA; Rosenbaum RM; Rosene GL; Rossi F; Rost FWD; Roth D; Ruch F; Ruddle FH; Lubs HA; Ledley RS; Shows TB; Roderick TH; Kim H; Brodie E; Rosales CL; Sadauskas P; Luksys L; Dabkevcius V; Sakharova AV; Sakharov DA; Samosudova NV; Ogieveckaja MM; Kalamkarova MB; Sandler M; Santti RS; Sasaki M; Takeuchi T; Satir P; Schauer A; Scher S; Haley PL; Schiebler TH; Schiemer H-G; Schlüns J; Schuster FL; Hershenov B; Scott JE; Scott TG; Seno S; Yokomura E-I; Itoh N; Yamamoto M; Shungskaya VE; Enenko SO; Lukyanova LD; Sarch EN; Shuter E; Jungalwala F; Robins E; Sierakowska H; Silverman L; Simard A; Daoust R; Smith EE; Smith RE; Fishman WH; Henzl M; Sobel HJ; Avrin E; Sorokin HP; Sorokin S; Squier CA; Waterhouse JP; Steinbach G; Steplewski Z; Stitnimankarn T; Stoward PJ; Straus W; Stumpf WE; Roth LJ; Sylvén B; Kanamura S; Templeton M; Tewari HB; Tyagi HR; Thalmann R; Glismann L; Thomas E; Tice LW; Tixier-Vidal A; Törö I; Bacsy E; Vadasz G; Rappay G; Tsou KC; Chang MY; Matsukawa S; Goodwin C; Lynm D; Seamond B; Van Der Ploeg M; Van Duijn P; Coulter JR; Pascoe E; Van Fleet DS; VanHouten WH; Vecher AS; Masko AA; Predkel KI; Reshetnikov VN; Tchaika MT; Velican C; Velican D; Vendrely C; Lageron A; Tournier P; Vialli M; Prenna G; Vilter V; Vittek J; Vogt A; Vollrath L; Von Mayersbach H; Vorbrodt A; Wächtler K; Wakabayashi K; Tamaoki B-I; Wald N; Ranshaw R; Weller RO; Welsch U; Werner G; Williams V; Morriss F; Willighagen RGJ; Wilson BW; Wohlrab F; Wolf PL; Horwitz JP; Freisler JV; Von Der Muehll E; Vazquez J; Wolman M; Yamada M; Iwata S; Yamaguchi H; Yataganas X; Gahrton G; Young IT; Zaccheo D; Grossi CE; Genta V; Riva A; Zacks SI; Sheff MF; Zamfirescu-Gheorghiu M; Serban M; Vladescu C; Chirulescu Z; Marcus N; Zelenin AV; Kirianova EA; Stepanova NG; Zeuthen E; Zimmermann H; Zugibe FT; Abrahamson DE; Anderson NG; Caspersson T; Cornell R; Dougherty W; Jirasek JE; Jonsson G; Leske R; Moyer FH; Schneider WC; Siegel HI; Sternberger L; Osserman EF; Weinstock A
Book chapter: ZWEITER INTERNATIONALER KONGREß FÜR HISTO- UND CYTOCHEMIE / SECOND INTERNATIONAL CONGRESS OF HISTO- AND CYTOCHEMISTRY / DEUXIÈME CONGRÈS INTERNATIONAL D’HISTOCHIMIE ET DE CYTOCHIMIE. 1964;p. 187-190
Physical and quantitative Methods, Autoradiography
Ritzén M; Gahrton G; Carlson L; Goldstein DJ; Friberg U; Burke JF; Rappay G; van Duijn P; Bosque PG; Werner G; Khrushchov NG; Kunz J
Visa fler

Forskningsbidrag

Use of ex vivo expanded natural killer cells as a treatment strategy for hematological malignancies with special emphasis on multiple myeloma
Swedish Research Council
1 January 2012 - 31 December 2014

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI